[
    {
        "pmid": "40819163",
        "title": "Risk factors for subsequent vertebral fractures after percutaneous vertebral augmentation in Asian populations: a systematic review and meta-analysis.",
        "abstract": "identify risk factor subsequent vertebral fracture percutaneous vertebral augmentation metaanalysis Articles 2019 2024 retrieved PubMed Cochrane Library Embase Web Science quality included study assessed using NewcastleOttawa Scale NOS data analysis performed R The R Project Statistical Computing Fourteen article comprising data 5673 patient included analysis Statistically significant difference identified age gender Tscore measured dualenergy Xray absorptiometry body mass index BMI Computed tomography Hounsfield unit CT HU value intravertebral cleft IVC multisegment vertebral fractures bone cement leakage contrast statistically significant difference observed hypertension history diabetes history thoracolumbar vertebral fracture postoperative Cobb angle surgical method（percutaneous vertebroplastypercutaneous kyphoplasty） puncture method unilateralbilateral puncture bone cement volume Asian populations advanced age female low Tscore low BMI low CT HU values presence IVC multisegment vertebral fractures bone cement leakage identified significant risk factor subsequent vertebral fracture following PVA Conversely history antiosteoporosis treatment identified protective factor whereas hypertension history diabetes history thoracolumbar vertebral fracture postoperative Cobb angle surgical method puncture method bone cement volume demonstrate significant correlation subsequent vertebral fracture PVA",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40819163/",
        "source_type": "Global"
    },
    {
        "pmid": "40819022",
        "title": "Diagnosis and treatment outcomes of primary lymphoma of the thyroid gland.",
        "abstract": "Primary thyroid lymphoma PTL rare extranodal malignancy accounting less 5 thyroid cancer unique algorithm management contrast type thyroid cancer surgery cornerstone management PTL usually show female predominance diffuse large Bcell lymphoma DLBCL prevalent pathological subtype study aimed assess thyroid lymphomas epidemiology pattern relapse diagnostic approaches prognostic features presenting 165year experience tertiary referral oncology center retrospective study assessed PTL patient managed January 2008 June 2024 tertiary referral center clinical diagnostic therapeutic followup data analyzed Sixteen patient included mean age 5934 year femaletomale ratio 17 case 688 diagnosed stage II DLBCL identified 938 patients Remission achieved half patient firstline therapy cure following secondline treatments patient died stage II time diagnosis median diseasefree survival DFS 35 months overall survival OS 375 months aware PTL facilitate timely initiation treatment Chemotherapy definitive treatment used alone surgery done diagnostic purposes PTL good prognosis however latestage disease linked worse outcomes study underscore importance multimodal diagnostic therapeutic strategy highlighting need research rare malignancy",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40819022/",
        "source_type": "Global"
    },
    {
        "pmid": "40818962",
        "title": "Genkwanin glycosides are major active compounds in Phaleria nisidai extract mediating improved glucose homeostasis by stimulating glucose uptake into adipose tissues.",
        "abstract": "Natural remedy used standalone treatment complementary modern medicine control type 2 diabetes Palau traditional leaf decoction Phaleria nisidai PNe selected treat hyperglycemia efficacy supported small clinical trial part reverse pharmacology approach investigated antidiabetic potential PNe bioactive compound alleviate insulin resistance dietinduced obese male mice Dietary supplementation PNe improves insulin sensitivity promotes glucose uptake adipose depots vitro PNe trigger glucose disposal murine human adipocytes upregulating Glut1 expression PKCERK12 signaling identify active constituent PNe conducted bioactivityguided fractionation deciphered genkwanin flavone glycoside bioactive principles Moreover demonstrate aglycone genkwanin GE improves insulin resistance comparable extent antidiabetic drug metformin finding present GE promising glucoregulatory phytochemical facilitates glucose uptake adipocytes thereby reducing systemic glucose load enhancing insulin sensitivity",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40818962/",
        "source_type": "Global"
    },
    {
        "pmid": "40818960",
        "title": "Misdiagnosis of diabetic ketoacidosis: a case report.",
        "abstract": "Abdominal pain caused diabetic ketoacidosis uncommon easily misdiagnosed abdominal pain caused ureteral stonesThis case highlight importance distinguishing etiologies particularly patient diabetes delayed recognition diabetic ketoacidosis result lifethreatening complications novelty lie emphasizing diagnostic challenge necessity clinician consider diabetic ketoacidosis even imaging suggests alternative causes case report describes 59yearold Han female patient admitted hospital generalized abdominal pain without obvious cause 3 days diagnosed left ureteral stones Initial imaging revealed left ureteral stone hydronephrosis prompting ureteral stent placement Despite antispasmodics analgesics stent insertion pain persisted Diabetic ketoacidosis subsequently confirmed laboratory tests Following comprehensive systemic treatment metabolic parameter successfully normalized patient recovered discharged hospital mechanism treatment approach abdominal pain caused ketoacidosis ureteral stone differ significantly Clinicians treating abdominal pain patient history diabetes consider possibility ketoacidosisinduced abdominal pain especially conventional antispasmodic analgesic treatment ureteral stone ineffective Prompt identification diabetic ketoacidosis via comprehensive clinical assessment laboratory investigation crucial avoid delay appropriate treatment Enhanced recognition overlapping symptom diabetic ketoacidosis ureteral stone minimize diagnostic error lead better patient outcomes",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40818960/",
        "source_type": "Global"
    },
    {
        "pmid": "40818843",
        "title": "Efruxifermin: one step closer to disease-modifying therapy in fibrotic MASH.",
        "abstract": "",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40818843/",
        "source_type": "Global"
    },
    {
        "pmid": "40818820",
        "title": "The Efficacy of Dietary Interventions for Prediabetes Management: An Umbrella Review of Meta-analyses.",
        "abstract": "Literature suggests prediabetes may reversible dietary interventions Despite numerous metaanalyses evaluating efficacy dietary intervention strategies lack umbrella review gather published metaanalyses assess reliability strength evidence Metaanalyses randomized controlled trial RCTs dietary intervention adult prediabetes collected Embase Emcare MEDLINE Ovid Nursing CNKI selected metaanalyses least 3 independent RCTs reestimate randomeffects pooled effect sizes Credibility evidence assessed using AMSTAR 2 NutriGrade Nine metaanalyses comprising 45 comparison 10814 participant included Among dietary intervention examined Vitamin supplementation led reduced fasting blood glucose SMD 0377 95 CI 0598 0165 decreased blood triglyceride SMD 0385 95 CI 0622 0147 reduced risk T2D onset RR 0897 95 CI 0810 0994 increased likelihood reverting normoglycemia RR 1238 95 CI 1074 1425 Prebiotic supplementation significantly reduced body fat SMD 1271 95 CI 2326 0216 Fructose replacement significantly reduced postprandial plasma glucose level compared glucose SMD 8275 95 CI 12663 3887 sucrose SMD 5176 95 CI 9558 0793 However credibility evidence limited small sample size heterogeneity identified several dietary intervention improve cardiometabolic health individual prediabetes credibility evidence weak need future largescale longterm highquality trial population PROSPERO CRD42024506257",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40818820/",
        "source_type": "Global"
    },
    {
        "pmid": "40818791",
        "title": "A qualitative study of healthcare provider perspectives on challenges and opportunities to improve diabetes self-management practices in rural Bangladesh.",
        "abstract": "qualitative study explores healthcare professionals perspective constraint opportunity diabetes selfmanagement practice among rural people type 2 diabetes mellitus T2DM Bangladesh also examines suggestion preference future intervention improve diabetes selfmanagement practice DSMP adherence health outcome METHODS Semistructured interview healthcare professional provide care adult T2DM Bangladesh across tertiary secondary primary care setting conducted using purposive sampling techniques Interviews transcribed thematically analysed using deductive framework based socioecological model Overall total 24 healthcare professional n  15 locallevel n  9 nationallevel interviewed Four key theme emerged healthcare system governmental support policy patient factors community influences rural healthcare system face major challenges including inadequate resources workforce shortages limited access essential medication equipment leading high burden healthcare providers Additionally diabetes care integration primary health system minimal compounded cultural belief fatalistic attitude toward disease management Healthcare professional suggested groupbased DSMP peer support home visit personalised care finding contribute valuable perspective global discourse DSMP rural settings particularly Bangladesh similar context within low middleincome country LMICs underscoring need contextspecific culturally sensitive interventions",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40818791/",
        "source_type": "Global"
    },
    {
        "pmid": "40818781",
        "title": "The material basis and mechanism of Xiaokening granules in the treatment of type 2 diabetes mellitus by AKT/mTOR/GSK3β.",
        "abstract": "Type 2 diabetes mellitus T2DM common type diabetes mellitus become global public health problem Since 2006 hospital course clinical treatment found Xiaokening granule observed significant ameliorative effect type 2 diabetes yet main effective components vivo metabolic processes potential mechanism action remain unclear material basis Xiaokening granule analyzed QTOFMS metabolite metabolic process plasma urine feces tracked analyzed Combined network pharmacology potential effect component potential therapeutic target screened Finally type 2 diabetes mellitus T2DM model established dbdb mouse evaluate therapeutic effect Xiaokening granules Western Blot used confirm regulatory effect Xiaokening granule key targets study analyzed metabolic process 56 key component effective material basis Xiaokoning granule plasma urine feces 7 component Benzoylnapelline calycosin rhein may key effective material basis AKT GSK3β mTOR may potential therapeutic targets Animal experiment also shown Xiaokening granule significantly improve level IL6 TNFα inflammatory factor diabetic mice significantly reduce abnormality MDA SOD indicators phosphorylation AKT mTOR GSK3β protein significantly inhibited Xiaokening granule treat type 2 diabetes inhibiting AKTmTORGSK3β phosphorylation levels",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40818781/",
        "source_type": "Global"
    },
    {
        "pmid": "40818772",
        "title": "Mortality Outcomes and ACE Inhibitor Use in Patients with Idiopathic Pulmonary Fibrosis.",
        "abstract": "ACE inhibitor ACEi widely used antihypertensive agent proven cardioprotective effects Previous mechanistic clinical study suggested ACEi therapy may slow disease progression reduce mortality idiopathic pulmonary fibrosis IPF ACEi use associate reduced allcause realworld population IPF patients so association also present COPD patients retrospective analysis conducted using electronic health record Clinical Practice Research Datalink CPRD GOLD database 2019 linked HES Admitted Patient Care ONS death registration data Patients IPF COPD stratified based ACEi use defined ≥3 prescription within five year preceding diagnosis matched age gender smoking history using propensity score matching Multivariable Cox regression analysis performed adjusting age gender body mass index smoking status index multiple deprivation diabetes mellitus chronic kidney disease common cardiovascular comorbidities IPF cohort competing risk analysis used account causespecific mortality study included 3579 patient IPF matched COPD control mean age 74 years 36 female Among IPF cohort 1326 37 ACEi users compared 1061 30 amongst COPD patients ACEi use associated improved survival independent coexisting comorbidities IPF patient HR  089 95 CI  081098 p  0013 similar association found COPD patient HR  109 95 CI  095125 p  0234 ACEi therapy independently associated reduced allcause mortality IPF COPD Prospective trial warranted confirm finding IPF populations",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40818772/",
        "source_type": "Global"
    },
    {
        "pmid": "40818742",
        "title": "Targeted Elimination of Senescent Cells by ProcyanidinC1 Improves Diabetic Wound Healing and Restores Skin Quality.",
        "abstract": "diabetic patients impaired wound healing serious complication characterized prolonged inflammation wound granulation tissue formation impaired reepithelialization Accumulating evidence show senescent cell play crucial role pathomechanism diabetic wounds study systematically evaluated role senescent cell diabetic wound healing diabetic mouse DM mice model including streptozotocininduced type DM mouse model dbdb type II DM mouse model actively assessed therapeutic potential ProcyanidinC1 PCC1 novel senolytic compound demonstrated diabetic mouse accumulated significant number senescent cells primarily fibroblasts normal skin wound tissues Local application PCC1 selectively eliminated senescent cells leading improved wound healing outcomes modulating NFκB signaling axis PCC1 administration effectively downregulated senescenceassociated secretory phenotype components thereby ameliorating immune dysregulation diabetic wounds therapeutic intervention concurrently revitalized functional capacity dermal fibroblast vascular endothelial cells stimulating coordinated matrix deposition architectural remodeling extracellular compartment Furthermore PCC1 treatment enhanced epidermal barrier function healing crucial aspect wound repair often impaired diabetes also found PCC1 would improve wound healing type II diabetic mouse Collectively finding elucidate complex detrimental role senescent cell diabetic wound repair establish PCC1mediated senolytic clearance promising therapeutic intervention",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40818742/",
        "source_type": "Global"
    },
    {
        "pmid": "40818660",
        "title": "GPR41 and GPR43 modulate rodent pancreatic α-cell function and growth.",
        "abstract": "SCFA receptor GPR41 GPR43 regulate βcell insulin secretion role αcells remains unknown despite hyperglucagonemia type 2 diabetes T2D Thus current study aim investigate ability synthetic GPR41 GPR43 agonist modulate αcell physiology responsiveness nutrient challenge Using αTC19 cell primary rat islet investigated role SCFA receptor glucagon expression secretion physiological insulin resistant condition associated highfat feeding HFD lactation L specific agonist AR420626 AR S24chlorophenyl33dimethylN5phenylthiazol2yl butanamide PA employed study mechanism involved Histological flow cytometry analysis islet demonstrated GPR41 GPR43 localized αcells Treatment αTC19 cell GPR41agonist AR GPR43agonist PA increased Gcg expression glucagon secretion low glucose AR also potentiated glucagon release high glucose effect recapitulated isolated islet demonstrating pertussis toxin sensitivity agonist effects HFDfed animal showed glucose intolerance early fasting hyperglucagonemia islet resistance glucose inhibition glucagon secretion together enhanced expression islet Gpr4143 Stimulation HFD islet synthetic agonist increased Gcg expression Pancreatic Gpr4143 level also transiently induced lactation although GPR41 activation lactating rat islet upregulated Gcg expression via Gαsubisub αcell replication finding position GPR41 promising therapeutic target modulating hyperglucagonemia improving glycemic control T2D supporting translational relevance diabetes intervention strategies",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40818660/",
        "source_type": "Global"
    },
    {
        "pmid": "40818595",
        "title": "The Effect of Isotretinoin Treatment for Acne Vulgaris on Height in Adolescents: A Retrospective Cohort Study Using the Rochester Epidemiology Project.",
        "abstract": "Isotretinoin first line treatment severe acne effect adolescent growth remain unclear assess effect isotretinoin final adult height height velocity adolescent treated acne retrospective cohort study used Rochester Epidemiology Project identify patient diagnosed acne 20052021 initiated isotretinoin oral antibiotic age 15 Height velocity calculated using measurement taken within one year pre postmedication initiation final height recorded 18 years Multivariable regression model adjusted age sex Among 226 isotretinointreated patient 1179 controls final height differ significantly group 067 cm CI 221 087 However isotretinointreated patient lower posttreatment height velocity 012 cmmonth CI 021 004 p  0005 greater reduction post versus pretreatment height velocity 031 cmmonth CI 054 007 p  0011 significant dosage effect observed study limited sample size potential unmeasured confounders predominantly nonHispanic white population isotretinoin may reduce height velocity associated negative effect final adult height among adolescent treated acne",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40818595/",
        "source_type": "Global"
    },
    {
        "pmid": "40818474",
        "title": "Blood phosphorylated tau for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis.",
        "abstract": "Plasma phosphorylated tau ptau biomarkers show promise transform clinical management Alzheimers disease providing accessible costeffective diagnostic tools ptau biomarkers emerged leading contender clinical implementation however comprehensive metaanalyses diagnostic performance aimed evaluate diagnostic performance plasma ptau biomarkers individual ptau assay identify biologically defined Alzheimers disease systematic review metaanalysis searched Embase MEDLINE PubMed Scopus Web Science article published July 1 1984 Dec 9 2024 reported discriminative accuracy plasma ptau biomarkers amyloidPET tauPET CSF neuropathological reference standards included cohort casecontrol crosssectional randomised controlled study recruited adult setting Articles excluded contain data ptau blood biomarker contain appropriate biological reference standard report diagnostic accuracy data included participant younger 18 years reported duplicate overlapping data another publication Summary data independently extracted eight authors Risk bias assessed using QUADAS2 primary outcome diagnostic performance plasma ptau biomarkers Alzheimers disease used bivariate randomeffects metaanalysis estimate pooled sensitivity specificity diagnostics odds ratio area receiver operating characteristic curve assessed certainty evidence using GRADE study done following PRISMADTA guideline registered PROSPERO CRD42023422143 6429 study identified search 312 study assessed eligibility 113 study included final analysis comprising 29 625 unique individuals Plasma ptau217 highestperforming biomarker identifying biologically defined Alzheimers disease pooled sensitivity 88·1 95 CI 86·789·5 moderate certainty evidence specificity 88·7 87·489·9 moderate certainty evidence area receiver operating characteristic curve AUROC 91·1 88·992·4 moderate certainty evidence diagnostic odds ratio 50·7 40·663·4 ptau181 pooled sensitivity 80·5 78·482·4 low certainty evidence specificity 76·4 74·178·6 low certainty evidence AUROC 81·5 80·282·9 low certainty evidence diagnostic odds ratio 13·4 11·416·7 ptau205 pooled sensitivity 76·6 70·781·6 moderate certainty evidence specificity 86·0 78·691·2 moderate certainty evidence AUROC 85·1 80·789·6 moderate certainty evidence diagnostic odds ratio 20·2 10·538·7 ptau212 pooled sensitivity 84·5 75·590·6 moderate certainty evidence specificity 87·3 79·592·5 moderate certainty evidence AUROC 90·3 86·694·1 moderate certainty evidence diagnostic odds ratio 41·2 22·077·3 ptau231 pooled sensitivity 75·2 71·378·8 moderate certainty evidence specificity 75·3 71·278·9 moderate certainty evidence AUROC 80·2 77·682·7 moderate certainty evidence diagnostic odds ratio 9·3 7·012·2 Approximately 90 study rated high risk bias used predefined externally derived thresholds Plasma ptau217 highly sensitive specific biomarker Alzheimers disease pathology despite high risk bias many studies Prospective clinical implementation study realworld setting needed characterise effect plasma ptau217 Alzheimers disease diagnosis clinical management McGill Faculty Medicine Fellowship",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40818474/",
        "source_type": "Global"
    },
    {
        "pmid": "40818414",
        "title": "Vascular dilation function correlates to pregnant outcomes in women with gestational diabetes mellitus.",
        "abstract": "Gestational diabetes mellitus GDM pose significant risk maternal fetal health necessitating deeper understanding pathophysiology interventions Vascular endothelial dysfunction play crucial role diabetic vascular complications relationship GDM outcome remains unclear study included 278 GDM patient categorized high low flowmediated dilation FMD group based median FMD values Clinical data glycemic parameters serum biomarkers assessed Pregnancy outcome compared groups logistic regression analysis performed evaluate associations demographic characteristic significantly differ FMD groups glycemic parameter significantly better high FMD group Negative correlation observed FMD glycemic parameters Patients low FMD higher rate adverse pregnancy outcomes combined test model incorporating FMD endothelin1 nitric oxide level showed superior predictive accuracy poor pregnancy outcomes Vascular endothelial dysfunction indicated impaired FMD correlate adverse pregnancy outcome GDM Multimarker approach may enhance risk stratification personalized management strategies",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40818414/",
        "source_type": "Global"
    },
    {
        "pmid": "40818398",
        "title": "Complete limb amputation due to amniotic band syndrome: Case report from a lower-middle-income country.",
        "abstract": "Amniotic Band Syndrome ABS rare congenital anomaly manifest varying type severity perinatal defect caused fibrous band generated injured amnion band trap extremity gradually cut blood supply causing structural functional defects necrosis partial complete amputation even death report female preterm Lowbirthweight baby left leg completely amputated calf right leg constricted blackened simultaneously born mother anemia gestational diabetes mellitus neonate received supportive treatment improving gradually laterit discharged incomplete treatment demand parent finally expired home Despite regular antenatal checkups condition fetus undiagnosed Poorquality prenatal ultrasound lack trained professional lowresource setting hinder early ABS detection Fetoscopic band release effective currently unavailable Bangladesh treatment include postnatal cosmetic surgery expose sad picture diagnosis treatment rare disease low middleincome country LMIC like Bangladesh ABS rare congenital condition often go undiagnosed LMICs due lack trained specialist technologies research coordinated effort national expert international community healthcare imperative ensure earliest diagnosis proper intrauterine postnatal treatment",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40818398/",
        "source_type": "Global"
    },
    {
        "pmid": "40818268",
        "title": "The effects of resistance training on glycemic control, cardiometabolic health, and body composition in middle-aged and older women with type 2 diabetes and overweight or obesity: A systematic review and meta-analysis.",
        "abstract": "explore effect resistance training glycemic control cardiometabolic markers body composition woman overweight obesity middleaged older type 2 diabetes mellitus Following guideline Preferred Reporting Items Systematic Reviews MetaAnalyses searched CINAHL PubMed MEDLINE EMBASE randomized controlled trial published English May 2025 Eligible study included resistance training intervention woman body mass index 25 kgmsup2sup type 2 diabetes mean participant age 45 year older Randomeffects metaanalyses conducted using Review Manager software subgroup analysis address heterogeneity Thirteen trial total 315 participant included Resistance training significantly reduced fasting glucose mean difference  2070 mg per deciliter 95  CI 3365 775 p  0002 glycated hemoglobin mean difference 066  95  CI 101 033 p  00002 total cholesterol lowdensity lipoprotein cholesterol diastolic blood pressure body mass index body fat percentage significant effect observed triglycerides highdensity lipoprotein cholesterol systolic blood pressure body weight Greater reduction fasting glucose observed training intensity 70  onerepetition maximum Resistance training effective improving glycemic control certain cardiometabolic risk factors body composition population finding support role targeted intervention highlight need research refine application",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40818268/",
        "source_type": "Global"
    },
    {
        "pmid": "40818183",
        "title": "Network pharmacology and untargeted metabolomics reveal the mechanisms of Bushen Kaixuan Tongluo formula in diabetic kidney disease.",
        "abstract": "Bushen Kaixuan Tongluo Formula BKT clinically validated Traditional Chinese Medicine shown promising renoprotective effect diabetic kidney disease DKD patients study investigated therapeutic mechanism BKT DKD using integrated approach combining network pharmacology untargeted metabolomics dbdb mice Network pharmacology identified 338 bioactive component BKT targeting 389 DKDrelated genes key pathway including AGERAGE HIF1 MAPK PI3KAkt signaling well autophagy BKT treatment significantly improved renal function reduced ACR ameliorated glucoselipid metabolism lowered GSP INS HOMAIR TC FFA attenuated renal pathology reduced glomerulosclerosis tubular injury fibrosis Untargeted metabolomics revealed 26 renal 28 urinary differential metabolite VIP  10 P  005 enrichment autophagy PPAR signaling linoleic acid metabolism kidney TCA cyclethiamine metabolism urine Key metabolite αdimorphecolic acid renal thiamine pyrophosphate urinary LysoPC 184 implicated BKTs renoprotective effects finding demonstrate BKT alleviates DKD multitarget modulation metabolic inflammatory stressresponse pathways synergistic action predicted network pharmacology validated metabolomics study provides scientific foundation clinical application BKT DKD treatment",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40818183/",
        "source_type": "Global"
    },
    {
        "pmid": "40818169",
        "title": "Modulation of cutaneous wound healing by Losartan: A focus on MCP-1 activity and collagen synthesis.",
        "abstract": "Losartan selective angiotensin II type 1 receptor AT1R antagonist shown antiinflammatory antifibrotic property may accelerate wound healing applied topically Impaired wound healing remains global health concern leading chronic wounds infection excessive scarring study first evaluate wound healing potential topically applied Losartan Fullthickness excisional wound created SpragueDawley rat treated topical Losartan 5  10  base cream left untreated Wound healing assessed macroscopically histologically day 10 20 30 postinjury addition analyzing myeloperoxidase MPO monocyte chemotactic protein1 MCP1 glycosaminoglycans GAGs hydroxyproline parameter wound closure rate collagen fiber alignment revascularization inflammatory cell infiltration evaluated Losartantreated wound showed significantly accelerated closure enhanced cytokeratin 14 CK14 improved epithelial regeneration reduced inflammatory infiltration MPO activity notably decreased especially early healing MCP1 modulation followed macrophage dynamics Histological result demonstrated enhanced fibroblast maturation revascularization organized collagen deposition Elevated level hydroxyproline GAGs confirmed improved extracellular matrix formation study first demonstrate efficacy topically applied Losartan promoting wound healing modulating inflammation enhancing matrix remodeling regulating CK14 expression finding support therapeutic repositioning Losartan novel topical agent pave way clinical development management chronic wounds including diabetic ischemic ulcers",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40818169/",
        "source_type": "Global"
    },
    {
        "pmid": "40818165",
        "title": "Apolipoprotein CIII in statin-treated type 2 diabetic patients: Its implications for plaque progression and instability: The pre-specified analysis from the OPTIMAL randomized controlled trial.",
        "abstract": "Apolipoprotein CIII ApoCIII variety proatherogenic properties Given hyperglycemia induces ApoCIII transcription apolipoprotein may promote coronary atherosclerosis type 2 diabetic patients aimed elucidate whether ApoCIII affect plaque progression instability statintreated type 2 diabetic patients OPTIMAL study prospective randomized controlled trial employed serial NIRSIVUS imaging evaluate efficacy glycemic control coronary atherosclerosis 94 statintreated type 2 diabetic patient UMIN000036721 these 78 patient ApoCIII level NIRSIVUS image baseline week 48 analyzed increase ApoCIII level week 48 observed 474  study participants Ontreatment LDLC level differ among participant without increase ApoCIII level 176 ± 055 vs 174 ± 055 mmolL p  091 Serial change IVUSderived atheroma volume similar two group 07 ± 22 vs 24 ± 16 mmsup3sup p  051 However greater progression NIRSderived maxLCBIsub4mmsub observed increase ApoCIII level 912 ± 248 vs 442 ± 235 p  0001 Even adjusting clinical characteristics maxLCBIsub4mmsub participant increase ApoCIII level still progressed 870 ± 249 vs 442 ± 235 p  0001 Moreover maxLCBIsub4mmsub less likely regressed patient increase ApoCIII level 162 vs 805  p  0001 Even achieving ontreatment LDLC14 mmolL maxLCBIsub4mmsub progressed association increase ApoCIII levels Circulating ApoCIII promoted accumulation lipidic plaque component statintreated type 2 diabetic patient suggesting ApoCIII residual risk requires therapeutic intervention",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40818165/",
        "source_type": "Global"
    },
    {
        "pmid": "40818112",
        "title": "The Diabetes Attitudes Wishes and Needs (DAWN)-SMI study: A cross sectional comparison of the psychosocial impact of diabetes in adults with and without severe mental illness.",
        "abstract": "People severe mental illness SMI 23 time likely diabetes general population Little known impact living diabetes people SMI study investigates psychosocial problem diabetes self management people SMI diabetes compared cross sectional survey data collected 258 adult diabetes SMI England 500 adult diabetes UK sample second Diabetes Attitudes Wishes Needs study DAWN2 Effect size ES test used quantify difference two sample adjusted diabetes type age gender treatment treatment duration diabetes complication comorbidities achieve comparability two samples Compared DAWN2UK sample people diabetes SMI reported poorer quality life WHOQOL ES 03 CI 05 01 p  0001 mental wellbeing ES 134 CI 173 95 p  0001 increased diabetes distress PAID5 ES 16 CI 0923 p  0001 people diabetes SMI reported negative impact diabetes SMI greater impact life diabetes mental illness impact profile 26 ± 11 vs diabetes impact profile 34 ± 10 p  0001 People SMI reported less engaged self management DAWN2UK population SDSCA6 ES 04 CI 07 01 p  001 psychosocial impact diabetes greater people SMI reduce inequality diabetes outcomes people SMI diabetes require tailored support diabetes management considers additional challenge associated living severe mental illness",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40818112/",
        "source_type": "Global"
    },
    {
        "pmid": "40818105",
        "title": "How do hypoglycaemias affect the everyday life of people with diabetes and are they able to treat them adequately?",
        "abstract": "investigate whether people type 1 type 2 diabetes respond adequately hypoglycaemia symptom participating treatment teaching programme Additionally explored hypoglycaemia impact patients everyday life difference individual without impaired awareness hypoglycaemia IAH crosssectional study included 340 adult participant type 1 n  156 type 2 diabetes n  184 undergoing insulin therapy University Hospital Jena Participants completed validated questionnaire participated structured interview hypoglycaemia Awareness hypoglycaemia measured using Gold Score diabetes distress PAID Scale PAID Score 0100 higher score higher distress 238 participant treated hypoglycaemia adequately type 1 diabetes 276 vs type 2 diabetes 247 p  0606 Significantly people without IAHtreated hypoglycaemia adequately type 2 279 vs 103 p  0047 type 1 diabetes 286 vs 231 p  0568 Hypoglycaemia altered daily routine 262 participants particularly type 1 diabetes type 1 diabetes 373 vs type 2 diabetes 201 p  0001 People type 1 type 2 diabetes reporting change daily routine higher diabetes distress score PAID 223 ± 160 vs 138 ± 135 p  0001 Fear hypoglycaemia associated higher HbAsub1csub value due people accepting elevated blood glucose levels Despite education programmes majority participant treat hypoglycaemia adequately Hypoglycaemic event significantly impact daily life associated increased diabetesrelated distress especially IAH",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40818105/",
        "source_type": "Global"
    },
    {
        "pmid": "40817913",
        "title": "Vitreous Olink Proteomics Uncovers Novel Inflammatory Proteins in Patients with Proliferative Diabetic Retinopathy.",
        "abstract": "Mounting research indicates inflammatory environment key driver advancement proliferative diabetic retinopathy PDR study analyze contrast 92 inflammatory cytokine level vitreous humor individual PDR ini  14 control subject diagnosed idiopathic macular hole IMH ini  11 using Olink inflammation panel Key finding revealed 22 differentially expressed protein DEPs comparing PDR IMH groups 21 protein showing increased expression one demonstrating decreased levels Among DEPs fibroblast growth factor 23 FGF23 emerged particularly promising candidate elevated expression observed retinal tissue diabetic dbdb mouse highglucose HG glyoxaltreated Müller glia MG cultures Functional study demonstrated conditioned medium HGexposed MG significantly enhanced endothelial cell proliferation migration tube formation Importantly proangiogenic effect markedly attenuated FGF23 activity blocked using neutralizing antibody suggesting critical role MGmediated angiogenesis hyperglycemic conditions Collectively finding demonstrated individual PDR exhibited elevated concentration multiple inflammatory cytokines Additionally FGF23 emerged promising new candidate targeted treatment condition",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40817913/",
        "source_type": "Global"
    },
    {
        "pmid": "40817873",
        "title": "Podocyte Proteomics Revealed hUCMSC-Exosomes Ameliorate Diabetic Kidney Disease through Inhibiting Talin-1 Mediated EMT.",
        "abstract": "Podocytes injury drive proteinuria diabetic kidney disease DKD Exosomes derived human umbilical cord mesenchymal stem cell hUCMSCs demonstrated therapeutic potential kidney diseases However effect hUCMSCs podocyte injury underlying mechanism DKD remain unexplored Fourdimensional labelfree quantitative proteomics performed global analysis protein sorted podocytes normal mouse NC group dbdb mouse DM group dbdb mouse treated hUCMSCs DMT group HUCMSCderived exosomes alleviated renal dysfunction podocyte epithelialmesenchymal transition EMT total 1765 protein quantified enrichment pathway related cytoskeleton organization phagocytosis oxidative stress apoptosis Talin1 downregulated diabetic podocytes upregulated following hUCMSC treatment Talin1 silencing exacerbated high glucoseinduced EMT study highlight potential hUCMSCderived exosomes therapeutic strategy DKD ameliorating Talin1mediated podocyte EMT",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40817873/",
        "source_type": "Global"
    },
    {
        "pmid": "40817831",
        "title": "Novel Dual and Triple Agonists Targeting GLP-1, GIP, Glucagon, and GDF15 for Type 2 Diabetes and Obesity Management.",
        "abstract": "rising global incidence type 2 diabetes mellitus T2DM obesity underscore critical public health challenge obesity serving primary contributor insulin resistance Current treatment modalities including SGLT2 inhibitor GLP1 receptor agonists shown efficacy glycemic control weight management remain insufficient patients review focus novel dual triple agonist targeting glucagonlike peptide1 GLP1 glucosedependent insulinotropic polypeptide GIP glucagon growth differentiation factor 15 GDF15 due emerging clinical importance recent preclinical progress peptidebased therapies amylin analogs beyond scope work addressed future reviews novel agents particularly GLP1GIP GLP1GDF15 GLP1GIPglucagon combinations leverage multiple metabolic pathway enhance glycemic control promote weight loss offer potential renal neurological benefits peptidebased therapies amylin analogs beyond scope work addressed future reviews novel agents particularly GLP1GIP GLP1GDF15 GLP1GIPglucagon combinations leverage multiple metabolic pathway enhance glycemic control promote weight loss offer potential renal neurological benefits Evidence suggests novel agent improve metabolic parameter may also offer cardioprotective antiinflammatory benefits advancement understanding mechanism action promising safety profile treatment warrant careful evaluation due potential adverse effects review aim provide comprehensive overview evolving landscape antidiabetic pharmacotherapy emphasizing unique benefit challenge emerging agent optimize clinical outcome T2DM management",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40817831/",
        "source_type": "Global"
    },
    {
        "pmid": "40817790",
        "title": "Chores Participation, Self-Efficacy, and Transition Readiness in Youths With Diabetes: Preliminary Results.",
        "abstract": "study investigated relationship chore participation diabetes management selfefficacy transition readiness among adolescent diabetes Fiftyfour youth participated average age 135 years CHORES survey evaluated chore participation STARx questionnaire assessed health care transition readiness Perceived Diabetes SelfManagement Scale PDSMS assessed selfefficacy Results showed involvement chore positively correlated transition readiness score iri  404 ipi  05 important subdomains transition namely selfmanagement provider communication Mediation analysis found selfefficacy significantly influenced link chore transition readiness suggests adolescent assume household responsibilities may develop greater confidence managing diabetes turn enhances readiness health care transition Encouraging chore participation improve transition readiness directly indirectly selfefficacy Understanding mechanism key designing patient education programs psychosocial intervention support transition Implications health care provider parent discussed",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40817790/",
        "source_type": "Global"
    },
    {
        "pmid": "40817763",
        "title": "Long-Term Effect of Periodontal Therapy on HbA1c Changes in Type 2 Diabetes.",
        "abstract": "Although prior study assessed effect nonsurgical periodontal therapy NSPT glycemic management short term account change diabetes medication longitudinal cohort study assessed effect NSPT HbA1c level clinical periodontal measure type 2 diabetes T2D patient periodontitis Medication change 1 prior 1 commencing NSPT considered total 154 nonsmoking T2D patient periodontitis received initial periodontal treatment professional mechanical plaque removal subgingival instrumentation root surface debridement oral hygiene instruction baseline Supportive periodontal care repeated subgingival instrumentation residual pocket provided 3 6 9 12 mo fullmouth periodontal examination assessing plaque bleeding probing gingival suppuration clinical attachment loss periodontal inflamed surface area PISA conducted baseline followup visits Glycemic management monitored via pointofcare HbA1c testing followup HbA1c record 12 mo NSPT obtained patients Linear mixedeffects model applied assess effect NSPT HbA1c time controlling important confounding effect medical history change diabetes medications mean HbA1c baseline 84 ± 16 Compared baseline HbA1c lower 070 073 068 077 3 6 9 12 mo respectively PISA reduced 3527 mmsup2sup 12 mo Moreover periodontal health parameter clinical attachment loss probing pocket depth fullmouth bleeding score significantly reduced 3 mo sustained 6 9 12 mo Participants stratified baseline HbA1c acceptable ≤80 ini  77 unacceptable 80 ini  77 groups unacceptable group showed HbA1c reduction 131 12mo followup compared 024 acceptable group present study demonstrated NSPT including maintenance significantly improved glycemic outcome T2D patients particularly baseline HbA1c 80",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40817763/",
        "source_type": "Global"
    },
    {
        "pmid": "40817759",
        "title": "Developing Stem Cell Therapy for Type 1 Diabetes Mellitus.",
        "abstract": "restricted availability cadaveric isolated human donor islet sharply limit progress clinical trial islet cell transplantation Furthermore hosts general pharmacologic immunosuppression invariably needed grant survival function human islet grafts former mandate validation new source insulin producing cells latter requires new strategy circumvent use general immunosuppressive agents possible solution problem could consist using human stem cells whose availability indefinite suitable both differentiation endocrine cell phenotypes genetic manipulation alter immunogenicity Pluripotent human stem cells either embryonic ESCs derived blastocyst originating adult somatic cells artificially induced pluripotency iPSCs finally multipotent human adult mesenchymal stem cell MSCs may considered MSCs difficult transdifferentiate Betalike cells hold powerful immunoregulatory properties pose ethical problems ESCs iPSCs show pros cons term ethical acceptance ESCs technical feasibility iPSCs pending immune problems might attenuated gene editing manoeuvre render cell immune evasive Early pilot clinical trial either ESCs iPSCs immunosuppressed T1D patient showed hyperglycemia reversed although challenge remain",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40817759/",
        "source_type": "Global"
    },
    {
        "pmid": "40817585",
        "title": "Design, Synthesis and Antidiabetic Activity of Novel Pyrrole-3-Carboximidamide Derivatives as Dipeptidyl Peptidase-4 Inhibitors.",
        "abstract": "Type 2 diabetes mellitus T2DM chronic metabolic disorder characterized insulin resistance impaired insulin secretion dipeptidyl peptidase4 DPP4 inhibitor emerged effective therapeutic option new series pyrrole3carboximidamide derivative designed synthesized evaluated DPP4 inhibitors synthesized compound exhibited favorable inhibitory activity DPP4 enzyme compound 5f 5g found potent inhibitor IC₅₀ value 1219 2308 nM respectively vivo study diabetic Wistar rat showed daily administration compound 5g 2 week resulted significant decrease blood glucose compared control group Moreover compound 5g effective reducing plasma glucose acute oral glucose tolerance test NMRI mice antiglycemic effect compound 5g comparable standard treatment sitagliptin effect normoglycemic rats vitro vivo antidiabetic property suggest compound 5g could considered promising candidate development antidiabetic medication",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40817585/",
        "source_type": "Global"
    },
    {
        "pmid": "40817397",
        "title": "The impacts of Crocin on serum cytokines concentrations in participants with metabolic syndrome: a double-blind randomized clinical trial study.",
        "abstract": "aim study investigate effect Crocin inflammatory cytokine profile patient Metabolic syndrome Mets Twentyeight patient Mets 15 case 13 controls randomly selected International Diabetes Federation IDF definite criterion doubleblind randomized clinical trial Participants divided two treatment groups group received 15 mg Crocin two tablet per day one received placebo eight weeks Inflammatory growth factor measured using sandwich chemiluminescence assay treatment result indicated inflammatory factor including IL2 IL10 VEGF INF γ significantly reduced P  005 patient Mets Crocin treatment Moreover significant difference detected among biochemical factor lipid profile FBG two groups result showed exclusive impact Crocin reduction serum inflammatory cytokines Crocin potential investigated useful therapeutic factor inflammatory diseasesClinical trial registration number IRCT2013080514279N1 Registration date 01022015",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40817397/",
        "source_type": "Global"
    },
    {
        "pmid": "40817355",
        "title": "Medical nutrition therapy for the management of type 2 diabetes mellitus.",
        "abstract": "Type 2 diabetes mellitus T2DM major global health concern Medical nutrition therapy key role T2DM management dietary intervention central improving glycaemic control overall metabolic health Growing evidence suggests certain dietary strategy exert direct metabolic benefit independent weight reduction Mediterranean diet consistently demonstrated metabolic cardiovascular benefits along improved glycaemic control even absence substantial weight reduction Lowenergy verylowenergy diets characterized moderate severe caloric restriction respectively also associated improvement cardiometabolic marker glycaemic regulation Ketogenic diet promote nutritional ketosis shown benefit glycaemic control insulin sensitivity metabolic outcomes often preceding substantial weight loss Intermittent fasting strategies alternateday fasting 52 model timerestricted eating likewise linked enhanced glycaemic control favourable metabolic cardiovascular effects although longterm efficacy safety require investigation Review aim provide evidencebased synthesis main nutritional strategy used treatment T2DM focus underlying mechanisms clinical efficacy potential sustainable longterm implementation",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40817355/",
        "source_type": "Global"
    },
    {
        "pmid": "40817337",
        "title": "General framework of nonlinear factor interactions using bayesian networks for risk analysis applied to road safety and public health.",
        "abstract": "complex systems understanding nonlinear interaction among risk factor essential accurate risk analysis However traditional linear model often fail capture complex interdependencies leading significant gap risk prediction aim study present novel approach risk analysis nonlinear risk interaction using Bayesian network BNs thereby providing broadly applicable method risk management mitigation Specifically study applies BNbased framework integrates conditional dependency nonlinear effect illustrate multifactor risk interaction operate synergistically Using stepbystep approach interaction among multiple risk factor first mathematically formalized framework applied case study road safety using crash report data Additionally second validation case public health type 2 diabetes risk included supplementary material illustrate broader applicability framework finding demonstrate BNs mathematical framework analyse complex interaction accurately traditional method can revealing amplifying mitigating effect individual risk factor outcomes approach offer accurate risk representation applicable road safety also complex environments healthcare environmental risk analysis",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40817337/",
        "source_type": "Global"
    },
    {
        "pmid": "40817201",
        "title": "Metabolomic insights into vitreous humor with therapy outcome in type 2 diabetic retinopathy.",
        "abstract": "therapeutic outcome Type 2 Diabetic Retinopathy T2DR following vitrectomy unsatisfactory definitive biomarker available predict treatment response Identifying biomarker correlated treatment efficacy crucial vitreoussituated lens retinamay influence retinal metabolic perturbations Vitreous sample collected vitrectomy metabolic profile analyzed using Ultraperformance Liquid Chromatography coupled Tandem Mass Spectrometry UPLCMSMS Statistical analysis conducted identify metabolite metabolic pathway correlated therapeutic outcomes Patients demonstrating poor therapeutic response exhibited elevated level specific metabolites including Dodecanoylcarnitine Linoleylcarnitine Stearylcarnitine Decanoic acid Proline Perturbed metabolic pathway included Fatty Acid Biosynthesis Beta Oxidation Long Chain Fatty Acids Mitochondrial BetaOxidation Short Chain Saturated Fatty Acids metabolite showed strong discriminatory power predicting positive outcomes Area Curve AUC value 0925 0885 0864 0811 0808 respectively study highlight potential Dodecanoylcarnitine Linoleylcarnitine Stearylcarnitine Decanoic acid Proline biomarkers predicting therapeutic outcome following vitrectomy T2DR finding provide novel insight metabolic factor influencing treatment response variability suggest pathway future therapeutic interventions",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40817201/",
        "source_type": "Global"
    },
    {
        "pmid": "40817127",
        "title": "Depressive symptoms and associated factors among patients with diabetes in public primary healthcare facilities in Kuwait city, 2024.",
        "abstract": "Depression affect nearly one four diabetes patient globally regional variation prevalence Previous study show nearly onethird type 2 patient screened positive depression crosssectional study conducted January March 2024 diabetic clinic three government primary healthcare center Kuwait City aimed assess prevalence depressive symptom associated factor among diabetes patients PHQ9 questionnaire administered via mobile linkQR scan either selfadministered intervieweradministered 11 59 patient exhibited depression symptom PHQ9 score  10 59 patient depressive symptom PHQ  10 81 n  48 age 40 years 66 n  39 females 64 n  38 Kuwait nationals 50 30 receiving treatment 10 years 54 n  32 comorbid hypertension 81 n  48 patient type 2 diabetes 71 n  42 last HbA1C  75 Smoking AOR  388 95 CI 1501012 insulin therapy combination oral hypoglycaemics insulin therapy AOR  281 95 CI 124637 significantly associated depression symptoms male less likely report depressive symptom AOR  035 95 CI 014086 Routine depression screening diabetes care recommended identify risk factor early reduce impact depression population",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40817127/",
        "source_type": "Global"
    },
    {
        "pmid": "40817039",
        "title": "Retinal hemoperfusion and vascular endothelial function after pancreatic transplantation.",
        "abstract": "",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40817039/",
        "source_type": "Global"
    },
    {
        "pmid": "40817030",
        "title": "Foot Temperature Monitoring in People With Diabetes Mellitus: A Systematic Review of Incidence and Risk With Meta-Analysis.",
        "abstract": "Diabetic foot ulcer represent serious complication diabetes mellitus often associated amputation hospitalizations Monitoring foot temperature allows early detection risk developing DFUs study compare foot temperature monitoring method patient diabetes mellitus assesses applicability early detection foot temperature differences systematic literature review conducted following Cochrane methodology electronic search carried across multiple scientific databases risk bias assessed using Rob2 tool metaanalysis performed using Cochrane platform Review Manager 54 Eight study included seven met criterion metaanalysis result indicate diabetic foot ulcer amputation less frequent temperature monitoring group compared control groups metaanalysis underscore potential foot temperature monitoring prevent diabetic foot ulcer recurrence Nurses implement intervention promote temperature monitoring adherence preventive measure raising awareness benefit actions",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40817030/",
        "source_type": "Global"
    },
    {
        "pmid": "40816955",
        "title": "Validation of the \"Hypoglycemia Fear Survey for Parents\" in Spanish for the detection of fear of hypoglycemia in parents of children with type 1 diabetes mellitus.",
        "abstract": "Fear hypoglycemia FoH parent child type 1 diabetes mellitus T1DM described barrier affect achievement therapeutic goal adherence treatment validating Hypoglycemia Fear Survey Parents HFSP Spanish assessing relationship score various clinical variables conducted psychometric analysis instrument evaluating feasibility internal consistency validity reliability intended setting population sample included total 149 participant 718 mothers mean age child 99 year SD 32 mean duration T1DM duration 39 year SD 35 mean glycated hemoglobin HbA1c 79 SD 19 participants 879 reported use new technology glucose monitoring adapted questionnaire consists 20 item grouped three dimensions Cronbach α total scale 092 HFSP significantly correlated general worry scale ρ  047 P  001 testretest reliability analysis showed strong positive correlation ρ  084 P  001 Variables family history T1DM caregiver educational level HbA1c level use glucose monitoring system significantly associated HFSP scores Spanish version HFSP valid reliable tool may assist health care professional identifying parental FoH guide development intervention aimed improving disease management children",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40816955/",
        "source_type": "Global"
    },
    {
        "pmid": "40816936",
        "title": "Pre-Ramadan education decreases hypoglycemic events in fasting group.",
        "abstract": "",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40816936/",
        "source_type": "Global"
    },
    {
        "pmid": "40816899",
        "title": "Utilization of telemedicine in the care of children with obesity.",
        "abstract": "Obesity chronic relapsing progressive disease increasing prevalence significantly impact health quality life even children associated increased risk metabolic cardiovascular disease insulin resistance type 2 diabetes mellitus hypertension dyslipidemia metabolic dysfunctionassociated steatotic liver disease Additionally obesity lead development sleep apnea syndrome orthopedic issues psychological complications cornerstone care educating whole family healthy lifestyle however may often challenging due obstacle time constraints limited access specialists low longterm adherence families Telemedicine offer innovative approach improving obesity treatment child digital tools online consultations smart applications wearable technologies enables effective monitoring dietary physical activity habits support mental health reduces time financial burden families Studies indicate combining inperson remote support along active involvement family members lead higher success rate weight reduction healthy lifestyle maintenance article focus use telemedicine treatment obesity children providing overview method applied field effectiveness context current scientific knowledge",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40816899/",
        "source_type": "Global"
    },
    {
        "pmid": "40816833",
        "title": "Triple Valve Infective Endocarditis in an Immunocompetent Patient.",
        "abstract": "Triple valve endocarditis remains extremely rare medically challenging due lack clinical evidence best strategy 70yearold man diagnosed type 2 diabetes hypertension dyslipidemia emphysema presented worsening dyspnea fatigue unintentional weight loss 5 months diagnosed triple valve infective endocarditis complicated decompensated heart failure severe thrombocytopenia medical treatment initial stage underwent successful surgical treatment strategy Enterococcal endocarditis constitutes 14 case multivalvular infective endocarditis associated relapse death case unique patient immunocompetent enterococcal multivalvular infective endocarditis index patient fulfill criterion antibiotic prophylaxis ended lifethreatening complications challenging European Society CardiologyAmerican Heart Association guidelinerecommended practice multidisciplinary approach reduces mortality medical optimization surgery crucial case highlight need tailored approach case meet standard antibiotic prophylaxis criteria",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40816833/",
        "source_type": "Global"
    },
    {
        "pmid": "40816829",
        "title": "Successful Rituximab Treatment of GPIHBP1 Autoantibody-Associated Hypertriglyceridemia.",
        "abstract": "50yearold woman triglyceride value 1640 mgdL routine laboratory tests Despite initiation fenofibrate icosapent ethyl rosuvastatin lowfat diet triglyceride value ranged 1200 8200 mgdL recurrent pancreatitis Testing negative mutation chylomicronemia gene LPL APOC2 APOA5 LMF1 GPIHBP1 Additional testing revealed elevated autoantibody GPIHBP1 2336 UmL normal 58 UmL decreased GPIHBP1 25 pgmL normal range 5701625 pgmL confirming GPIHBP1 autoantibody syndrome GPIHBP1AAS patient received rituximab 1000 mg infusion 2 dos given 3 week apart Triglycerides decreased 1746 81 mgdL within 4 month remained normal 12 month later without repeat dosing GPIHBP1AAS recently described associated severe hypertriglyceridemia recurrent pancreatitis case treatment rituximab effective GPIHBP1AASassociated hypertriglyceridemia recognized successfully treated rituximab",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40816829/",
        "source_type": "Global"
    },
    {
        "pmid": "40816736",
        "title": "What Clinicians Need to Know About Glucagon-like Peptide 1 Agonists.",
        "abstract": "interplay metabolic health autoimmune disease psoriasis PsO psoriatic arthritis PsA garnered increasing attention Obesity key feature metabolic syndrome exacerbates disease severity conditions prompting exploration treatment addressing immune system metabolism Glucagonlike peptide 1 receptor agonist GLP1RAs primarily used type 2 diabetes mellitus demonstrated benefit beyond glycemic control including promoting weight loss improving metabolic health potentially modulating immune responses also dual GLP1 glucosedependent insulinotropic polypeptide receptor agonist similar potentially superior capabilities throughout manuscript collectively known GLP1RA Recent study also suggest GLP1RAs may help manage PsO PsA patient obesity medication may offer dual benefit reducing inflammation addressing metabolic abnormality like insulin resistance hyperlipidemia article report presentation given Group Research Assessment Psoriasis Psoriatic Arthritis GRAPPA 2024 annual meeting underscoring potential GLP1RAs therapeutic option particularly obese patient PsO PsA Although promising evidence supporting GLP1RAs treating PsO PsA remains limited necessitating clinical research evaluate safety efficacy",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40816736/",
        "source_type": "Global"
    },
    {
        "pmid": "40816708",
        "title": "Adipose tissue NLRP3 inflammasome: a therapeutic target in obesity and type 2 diabetes mellitus.",
        "abstract": "Adipose tissue identified crucial player release proinflammatory mediators result chronic inflammatory state predisposing individual obesity insulin resistance IR type 2 diabetes mellitus T2DM major approach tackling disease involves targeting molecular sensor respond nutritional cue metabolic status trigger early phase inflammatory cascades Among sensor nucleotide oligomerization domain NOD leucinerich repeat pyrin domaincontaining protein 3 NLRP3 inflammasome Therapeutic strategy targeting adipose tissue NLRP3 inflammasome show potential management obesity T2DM review provide insight potential current therapeutic strategies recent clinical advances",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40816708/",
        "source_type": "Global"
    },
    {
        "pmid": "40816639",
        "title": "Apoptotic neutrophil membrane-modified nanoparticles promote wound healing by enhancing efferocytotic capacity of dendritic cells.",
        "abstract": "Chronic large wound healing failure pose significant challenge clinical practice major difficulty wound healing concern limited efferocytic activity dendritic cell DCs Focusing critical role DCs efferocytosis chronic wound healing study proposes dualpathway intervention strategy Firstly basis mechanism SLC7A11 abnormally highly expressed diabetic wound inhibits efferocytic activity DCs novel inhibitor HG106 utilized target inhibit SLC7A11 significantly enhancing clearance efficiency apoptotic cell DCs Secondly inspired physiological apoptotic signal neutrophils apoptotic neutrophil membrane ANMmodified liposome HG106ANMLip constructed enhances recognition uptake nanoparticles DCs surface phosphatidylserine PS signal synergistically activates MERTKAXL receptor pathway initiate enhance efferocytosis improving inflammatory microenvironment diabetic mouse large wound model Bama pigs HG106ANMLip demonstrates good promoting effect wound healing summary study present innovative synergistic strategy chronic wound treatment utilizing dual mechanism molecular regulation biomimetic delivery reshape inflammatory microenvironment",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40816639/",
        "source_type": "Global"
    },
    {
        "pmid": "40816632",
        "title": "Optimizing Hospital Billing by Using Data from the Vascular Quality Initiative.",
        "abstract": "Hospitals reimbursed inpatient admission Medicare based principal Medicare severity diagnostic related group MSDRG assigned admission MSDRGs complication comorbidity CC major complication comorbidity MCC increase reimbursement reflect added cost caring complex patients Undercoding DRG complexity shown result unrecovered reimbursement financial loss hospitals hypothesized granular objective data collected trained abstractor Society Vascular Surgery Vascular Quality Initiative SVS VQI could used improve MSDRG coding accuracy detecting CC MCCs might missed standard coding process Medicarelinked VQI Peripheral Vascular Intervention PVI registry queried identify patient underwent admission PVI procedure 230 center 201019 Patients included index DRG represented PVI procedure Cases grouped without CCMCC vs with CCMCC PVI registry characteristic group compared Logistic stepwise regression used identify variable predicting CCMCC billing model used calculate variation expected number admission qualifying CCMCC center compared observed number actually billed across centers 40822 admission associated PVI treatment analyzed 76 billed CCMCC rate varied substantially across 230 hospitals 48100 Stepwise regression identified preexisting congestive heart failure diabetes mellitus dialysis prior amputation dependent functional status plus posttreatment cardiac renal pulmonary access site complications amputation longer length stay independently associated hospital billing MSDRG CCMCC model highly accurate cstatistic 082 expected number case billed with CCMCC exceeded observed number 89230 centers suggesting underbilling 39 centers Data available VQI PVI registry accurately identified admission billed VQI hospital MSDRGs CC MCC multivariable model could used prepare report participating hospital identify case likely justify MSDRG coding CC MCC special attention coders would intended supplant existing coding systems rather provide additional validation benchmarking could help avoid undercoding loss hospital revenue could provide added value VQI hospital additional cost help offset cost VQI participation",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40816632/",
        "source_type": "Global"
    },
    {
        "pmid": "40816559",
        "title": "Tracheobronchoplasty for Excessive Dynamic Airway Collapse and Tracheobronchomalacia: A Comparative Analysis of Distinct Airway Disorders.",
        "abstract": "Excessive dynamic airway collapse EDAC tracheobronchomalacia TBM distinct etiology excessive central airway collapse EDAC characterized excessive anterior displacement posterior membrane TBM due weakness cartilaginous rings compare outcome tracheobronchoplasty across two pathologies singlecenter retrospective study including patient underwent tracheobronchoplasty 20182023 Preoperative dynamic computed tomographic scan reviewed four airway expert patient classified two group EDAC TBM based consensus diagnosis 73 consecutive patient underwent tracheobronchoplasty consensus diagnosis EDAC n47 TBM n26 included Patients EDAC less likely diabetes 15 vs 54 p001 likely undergo robotic tracheobronchoplasty 30 vs 4 p001 significant difference rate minor complication 60 vs 81 p007 major complication 21 vs 35 p017 overall ClavienDindo score 21 vs 2175 p021 Intensive care unit hospital length stay rate 30day readmissions home discharge also similar group achieved clinically meaningful improvement qualityoflife score 6minute walk test first followup Differentiating EDAC TBM challenging clinician due overlapping clinical symptoms Despite anatomic differences surgical outcome comparable support role tracheobronchoplasty definitive treatment excessive central airway collapse regardless etiology Diagnostic differentiation remains important mechanistic understanding preclude surgical candidacy",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40816559/",
        "source_type": "Global"
    },
    {
        "pmid": "40816531",
        "title": "Stachydrine Mitigates High Glucose-Induced Apoptosis in Human Lens Epithelial Cells by Activating Mitophagy.",
        "abstract": "Diabetic cataract DC prevalent complication diabetes condition often lead significant visual impairment and cases blindness Recent study highlighted potential protective effect natural plant extract context DC Stachydrine STA alkaloid derived Leonurus heterophyllus Sweet identified natural compound superior bioavailability fewer side effect conventional antioxidants However protective role highglucoseinduced lens epithelial cell damage remains fully elucidated study established highglucose model using HLEB3 cell assessed apoptosis following STA treatment Mitochondrial network morphology analyzed using ImageJ software investigate role autophagy STAs effects employed autophagy inhibitor 3Methyladenine 3MA result indicated high glucose exposure decreased autophagosome formation lysosomal activity STA treatment significantly increased both Furthermore STA enhanced LC3B expression reduced P62 levels counteracting effect high glucose Regarding mitochondrial morphology STA effectively restored shape branching area diminished high glucose exposure Additionally STA effectively ameliorated mitochondrial network damage induced high glucose Notably cell treated 3MA STAs protective effect apoptosis mitochondrial morphology significantly reversed conclusion finding suggest STA exerts protective effect highglucoseinduced damage regulating mitophagy autophagydependent mechanism may hold therapeutic potential treatment diabetic cataract",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40816531/",
        "source_type": "Global"
    },
    {
        "pmid": "40816448",
        "title": "Clinical Outcome of Redo-Surgery for Recurrent Chronic Subdural Hematoma: A Systematic Review and Meta-analysis combined with A Case Series.",
        "abstract": "Chronic subdural hematoma CSDH becoming prevalent particularly aging populations 20 recurrence rate postsurgery Burr hole craniostomy BHC standard treatment recurrence remains significant challenge study evaluates incidence second CSDH recurrence management clinical outcome following various hematoma evacuation procedure literature cohort systematic review identified eight study 183 patients Additionally analysed 63 consecutive patient undergoing reoperation recurrent CSDH centre assessing second recurrence rates clinical outcomes impact comorbidities antithrombotic medication Metaanalysis showed pooled second recurrence rate 20 95 CI 1330 versus 159 cohort second recurrence occurred within month postsurgery Clinical outcome unfavourable patient residual symptom achieving moderate poor functional recovery mRS 24 Comorbidities diabetes significantly influence recurrence rates contrast previous reports use antithrombotic medication associated significantly lower recurrence rate cohort Redosurgery currently primary treatment subsequent recurrent CSDH lead unfavourable outcomes Given high recurrence rate poor functional recovery need improved treatment approach address underlying pathophysiology CSDH research needed evaluate effectiveness middle meningeal artery embolization MMAe context recurrence improving clinical outcomes",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40816448/",
        "source_type": "Global"
    },
    {
        "pmid": "40816361",
        "title": "Comment on \"Metformin treatment improves depressive symptoms associated with type 2 diabetes: A 24-week longitudinal study\".",
        "abstract": "",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40816361/",
        "source_type": "Global"
    },
    {
        "pmid": "40816089",
        "title": "Identification and characterization of novel α-glucosidase inhibitory peptides from sweet potato protein through heating combined with high hydrostatic pressure-assisted enzymatic hydrolysis.",
        "abstract": "Sweet potato fifth largest food crop China widely utilized starch production study aimed prepare identify αglucosidase inhibitory peptide sweet potato protein evaluate stability inhibitory kinetics vivo effects result indicated alcalase optimal protease combination heating high hydrostatic pressure effective pretreatment optimal enzymatic condition determined Peptide fraction molecular weight 3 kDa exhibited superior αglucosidase inhibitory activity good stability Three novel peptide QAGPDPW WESGPW GTPPPPPPPPKE high αglucosidase inhibitory efficiency ICsub50sub  158 414 324 mgmL identified liquid chromatographytandem mass spectrometry molecular docking vitro activity validation Animal experiment showed SPP1 three novel peptide effectively delayed postprandial blood glucose levels finding provide scientific basis application sweet potato peptide potential functional ingredient diabetes management",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40816089/",
        "source_type": "Global"
    },
    {
        "pmid": "40816035",
        "title": "Bacoside-A from Bacopa monnieri (L.) Wettst.: Molecular targets, preclinical insights, and therapeutic potential in type 2 diabetes mellitus and neurodegeneration.",
        "abstract": "Bacopa monnieri BM traditional Ayurvedic herb emerged promising multifunctional therapeutic plant managing type 2 diabetes mellitus T2DM comprehensive review examines molecular cellular systemic mechanism underlying antidiabetic effect BM key phytoconstituent bacoside A Evidence vitro vivo silico model reveals BM improves insulin sensitivity restores βcell functionality suppresses hepatic gluconeogenesis attenuates oxidative stress inflammation Notably recent silico docking study demonstrate strong interaction bacosideA PPARγ highlighting potential modulate metabolic neuroprotective pathways addition metabolic regulation emerging evidence support role BM addressing diabetesassociated neurodegenerationa condition characterized insulin resistance brain linked cognitive dysfunction neurodegeneration BacosideA BM extract modulate AMPAtype glutamate receptors downregulate proapoptotic marker like Bax mitigate oxidativenitrosative stress neuronal tissues thereby supporting cognitive resilience diabetic states neuroprotective action position BM dualtargeting botanical agent T2DM diabetesassociated neurodegeneration Furthermore integration multiomics data including transcriptomics metabolomics illuminated BMs biosynthetic pathway multitargeted pharmacological profile Network pharmacology proteinprotein interaction analysis confirm bacosideAs regulatory role NOTCH signalling insulin receptor expression hepatic enzyme modulation Collectively finding validate BM viable lowtoxicity candidate nextgeneration phytopharmaceutical development holistic management diabetes complications",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40816035/",
        "source_type": "Global"
    },
    {
        "pmid": "40815910",
        "title": "Amputation trends among people who use drugs in the context of Philadelphia's increasingly xylazine adulterated drug supply.",
        "abstract": "Xylazineadulterated fentanyl rapidly spread across United States increasingly detected overdose death Philadelphia PA medical examiner reports clinical testing widescale drug checking Xylazine use associated wound may lead amputation extent outcome explored Utilizing 10th revision International Classification Diseases ICD10 codes conducted deidentified retrospective analysis data patient identified opioid related disorder ICD10 code F11 admitted four different hospital Philadelphia PA 2018 2023 Exposure xylazine use active substance use among sample confirmed Year proxy xylazine adulteration examined association amputation using multivariable logistic regression Demographics diabetes number visit leaving treatment completion examined factor associated amputation 20595 acute care visit among 12047 unique patient F11 diagnosis Among patients 211 received ≤ 1 amputation across 277 visits incidence amputation increased 081  2018 155  2023 adjusted odds receiving amputation 208 greater 20222023 20182019 OR 218 95  CI 151 314 p  0001 AOR 208 95  CI 143 301 p  0001 odds receiving amputation among individual ICD10 F11 code rose alongside increased presence xylazine drug supply xylazine continues spread throughout United States health provider need information better address risk factor amputation develop protocol decrease incidence PWUO leaving treatment completion",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40815910/",
        "source_type": "Global"
    },
    {
        "pmid": "40815892",
        "title": "Social jetlag and obstructive sleep apnea severity: A retrospective study based on polysomnography.",
        "abstract": "Social jetlag representing misalignment endogenous circadian rhythm socially imposed sleep schedules associated various adverse health outcomes However potential relationship obstructive sleep apnea OSA severity quantified apneahypopnea index AHI remains unclear retrospective study analyzed data participant OSA AHI ≥5 eventshour completed sleep questionnaire underwent polysomnography sleep center Exclusions included nonOSA prior OSA treatment shift work sleepaffecting medication use incomplete data Social jetlag defined actual difference midsleep work day free days categorized minimal 1 h moderate 1 2 h severe ≥2 h Multiple linear regression assessed association social jetlag AHI adjusting age gender body mass index BMI history smoking alcohol hypertension hyperlipidemia diabetes Mediation analysis evaluated Epworth Sleepiness Scale ESS mediator subgroup analysis generalized additive model GAM exploring effect modification nonlinearity Among 2383 analyzed participants severe social jetlag independently associated higher AHI β  690 95  CI 218 1161 p  0004 ptrend  0014 unlike moderate group p  0389 ESS mediated 194  effect indirect effect β  046 95  CI 022 072 p  0001 matched cohort analysis stratified social jetlag severity n  637 AHI ESS rose social jetlag severity AHI 349 vs 394 vs 455 eventshour p  0001 ESS 101 vs 112 vs 118 p  0015 habitual sleep duration decreased 70 vs 68 vs 66 h p  0013 Stronger association observed male β  294 95  CI 134 454 p  0001 pinteraction 0001 smoker β  331 95  CI 090 571 p  0007 pinteraction  0003 significant effect BMI 2428 kgmsup2sup nonhypertensive nondiabetic subgroup all p  005 GAM analysis revealed gradual nonlinear AHI increase social jetlag 2 h accelerating beyond 2 h Severe Social jetlag independently increase AHI individual OSA partially mediated daytime sleepiness pronounced effect male smokers finding suggest circadian misalignment potentially modifiable factor influencing OSA severity",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40815892/",
        "source_type": "Global"
    },
    {
        "pmid": "40815832",
        "title": "Effects of Acute Time-Restricted Eating on Inflammation in Individuals With Psoriasis: Protocol for a Case-Control, Prospective Study.",
        "abstract": "Psoriasis chronic inflammatory disease associated multiple comorbidities including metabolic syndrome cardiovascular disease Although specific dietary interventions intermittent fasting caloric restriction shown ameliorate inflammation promote weight loss effect intervention independent weight loss remains unclear Timerestricted eating TRE type intermittent fasting limit daily eating window fixed number hours Recent study suggest TRE may improve immune function individual metabolic syndrome cardiovascular risk factors crucial advantage TRE investigated dietary restriction strategy reported high adherence rate making feasible intervention longterm use Therefore exploring effect TRE metabolic immunological parameter psoriasis warranted study designed evaluate effect shortterm isocaloric TRE independent weight loss immune cell function serum metabolite profile volunteer mildtomoderate psoriasis compared healthy individuals casecontrol prospective study performed 10 healthy male participant 10 age BMI sexmatched individual mildtomoderate psoriasis individual psoriasis stable disease treated topical therapy without exposure immunomodulatory biologics study conducted National Institutes Health Clinical Center Immune profiles glucose handling energy expenditure participants weight assessed baseline 3 day TRE following daily 6hour eating window 18hour fast trial commenced June 2021 completed February 2023 total 20 participant enrolled10 mildtomoderate psoriasis 10 age BMI sexmatched healthy individuals time manuscript submission data processing ongoing Multiomic datasets including gene expression surface intracellular protein levels metabolite profiles generated peripheral blood mononuclear cells CD4supsupenriched Tcells serum samples integrated bioinformatics analysis reported data analysis completed clinical protocol designed characterize effect short term 3day TRE psoriasis independent weight loss comparing immune cell regulatory response healthy individual psoriasis specifically aim map molecular pathway activated TRE assess affect immune cell composition activation metabolism Additionally component metabolic response isocaloric TRE explored Insights dietary intervention impact metabolism immune system enhance understanding pathogenesis psoriasis may reveal new therapeutic avenue managing inflammatory condition ClinicalTrialsgov NCT04728165 httpsclinicaltrialsgovstudyNCT04728165",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40815832/",
        "source_type": "Global"
    },
    {
        "pmid": "40815559",
        "title": "Community of Practice Implementation: Leveraging Veterans Affairs/Department of Defense Diabetes Clinical Practice Guidelines and Data Insights.",
        "abstract": "Effective management patient care delivery within Veterans Affairs VA Department Defense DOD healthcare system requires innovative strategy implement clinical practice guideline CPGs author explore expansion strategy leveraging Strategic Analytics Improvement Learning data Electronic Quality Measures dashboard Patient Aligned Care Teams across Veterans Health Administration enterprise multidisciplinary national virtual Community Practice CoP using subject matter expert presentation utilize VADOD CPGs strategic method implementation enhance patient outcome developed implemented work aim detail development implementation virtual CoP integrates multidisciplinary expertise data analytics enhance CPG adoption implementation implication CPG CoP discussed reflect ongoing success growth programs CPG CoP",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40815559/",
        "source_type": "Global"
    },
    {
        "pmid": "40815548",
        "title": "Positive Airway Pressure Therapy for Obstructive Sleep Apnea in High-Risk Pregnancy: A Meta-Analysis.",
        "abstract": "aimed assess effect positive airway pressure PAP therapy highrisk pregnancy patient OSA Studies systematically searched PubMed Embase Web Science Cochrane Library Articles comparing PAP therapy treatment nonPAP treatment modalities waitlist sham PAP nasal dilator strip highrisk pregnancy patient OSA included Outcomes interest included fasting plasma glucose FPG estimated insulin resistance gestational diabetes blood pressure measurements hypertensive disorder pregnancy cesarean section Epworth Sleepiness Scale birth weight Apgar 1 5 min preterm delivery fetal growth abnormalities neonatal intensive care unit admission Mean difference MD used continuous outcome risk ratio binary endpoints 95 confidence interval CI Seven study involving 696 patient included 328 patient treated PAP therapy PAP therapy associated lower FPG MD 650 95 CI 1064 236 p  0002 Isup2sup  32 improved insulin resistance indicated reduced HOMAIR level MD 090 95 CI 115 065 p  001 Isup2sup  0 significant difference observed maternal neonatal outcomes finding suggest PAP therapy may benefit highrisk pregnant woman OSA improving certain maternal outcome related glucose metabolism effect maternal neonatal outcome limited",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40815548/",
        "source_type": "Global"
    },
    {
        "pmid": "40815441",
        "title": "Influence of Language and Physician-Patient Racial Concordance on Diabetes Control: An Analysis of Consultations in California Clinics.",
        "abstract": "compare proportion patient diabetes metabolic control three health clinic attended Mexican doctor vs nonMexican doctors Longitudinal analytical study three clinic California data 8979 consultation 2023 analyzed Control patient diabetes evaluated based nationality physician MexicannonMexican type consultation firsttime followup referral Nephrology department Frequency analysis chisquare performed estimate risk selected outcome uncontrolled diabetes referral nephrology service Hosmer Lemeshow goodnessoffit test applied Better control observed consultation patient diabetes seen Mexican physician compared nonMexican physician  162 142 184 Likewise percentage patient referred Nephrology almost triple nonMexican physician compared Mexican physician  269 184 392 cultural linguistic concordance Mexican physician Spanishspeaking patient may contribute improved diabetes control could lead greater engagement primary care service among newly diagnosed diabetes patients",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40815441/",
        "source_type": "Global"
    },
    {
        "pmid": "40815433",
        "title": "Feasibility of continuous glucose monitoring in children with diabetic ketoacidosis: an exploratory observational study.",
        "abstract": "Diabetic ketoacidosis DKA lifethreatening complication diabetes leading cause Pediatric Intensive Care Unit PICU admissions use continuous glucose monitoring CGM acute critical phase DKA rarely explored remains uncertain due concern accuracy utility setting frequent capillary glucose measurement standard practice Data collected medical record patient admitted PICU newonset DKA initial presentation type 1 diabetes T1D Mean absolute relative difference MARD Clarke Error Grid CEG analysis used assess CGM accuracy Data 19 patient mean age 99 ± 34 years included Within first 48 h 16 hypoglycemic episode recorded CGM detecting 14 episode capillary glucose detecting two total 238 matched pair capillary CGM interstitial glucose value analyzed Statistical analysis found capillary glucose value significantly higher interstitial value p  0001 overall MARD 145 CEG analysis indicated 891 matched pair within zone B CGM might useful pointofcare tool provides valuable information may help clinician make timely management decisions ability CGM indicate trend glucose fluctuation could main clinical advantage particularly anticipating preventing potentially dangerous hypoglycemic events thereby optimizing patient management safety • DKA emergency require close glucose monitoring Standard methods capillary glucose monitoring venous blood glucose measurements limitation term comfort frequency trend detection • CGM currently rarely used PICU DKA due lack clinical trials resulting uncertainty accuracy pediatric DKA Additionally CGM FDAapproved use inpatient manage diabetes emergencies • CGM may benefit child DKA onset • DKA management PICUs showing glucose trend enabling hypoglycemia detected early supporting timely interventions reducing workload minimizing patient discomfort fewer capillary punctures",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40815433/",
        "source_type": "Global"
    },
    {
        "pmid": "40815384",
        "title": "Repurposing nitazoxanide in type 2 diabetes mellitus: a randomized controlled trial.",
        "abstract": "Preclinical data suggest nitazoxanide NTZ potential PPARγ agonist potential benefit type 2 diabetes pilot trial aimed explore tolerability preliminary effect NTZ addon therapy existing metforminvildagliptin combination glycemic control inflammatory biomarkers type 2 diabetes patients Eightyeight patient analyzed control NTZ group 44 per group patient treated metforminvildagliptin combination NTZ group received 500 mg nitazoxanide orally twice daily primary outcome glycemic control assessed glycated hemoglobin HbA1c fasting blood glucose Secondary outcome included fasting insulin serum interleukin6 IL6 high mobility group box 1 HMGB1 asprosin malondialdehyde MDA outcome measured baseline three months betweengroups comparison revealed significantly lower inflammatory marker NTZ compared control IL6 2364 ngL 21003271 vs 3252 ngL 29633613 HMGB1 1046 ngmL 6371461 vs 2260 ngmL 20182737 P  0001 both HbA1c fasting blood glucose insulin asprosin MDA considerably different two groups Markedly lower level IL6 P  0009 HMGB1 P  0001 asprosin P  0002 MDA P  0001 observed following NTZ treatment Conversely IL6 HMGB1 increased significantly control group P  0001 both biomarkers change significantly groups NTZ may alleviate oxidative stress inflammation type 2 diabetes despite improvement glycemic parameters trial registered ClinicalTrialsgov name Nitazoxanide Adjuvant Therapy Type 2 Diabetes Mellitus identifier NCT06010992 Registration date 82023",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40815384/",
        "source_type": "Global"
    },
    {
        "pmid": "40815371",
        "title": "Scavenging acrolein with 2-HDP preserves neurovascular integrity in a rat model of diabetic retinal disease.",
        "abstract": "Diabetic retinal disease DRD characterised progressive neurovascular unit NVU dysfunction often occurring visible microvascular damage previous study suggested accumulation acrolein ACRderived protein adduct retinal Müller cell neuronal protein may contribute NVU dysfunction diabetes although yet directly tested study evaluated effect novel ACRscavenging drug 2hydrazino46dimethylpyrimidine 2HDP retinal NVU dysfunction experimental diabetes explored potential systemic delivery humans Sprague Dawley rat divided three groups nondiabetic rats streptozocin STZinduced diabetic rats STZinduced diabetic rat treated 2HDP drinking water throughout duration diabetes Endpoint measure taken varying time points ranging 1 6 month postdiabetes induction Retinal function structure evaluated using electroretinography ERG spectraldomain optical coherence tomography SDOCT Retinal vessel calibre BP vasopermeability assessed Evans Blue leakage also monitored Immunohistochemistry employed assess retinal neurodegenerative vasodegenerative changes cytokine array used investigate effect 2HDP diabetesinduced retinal inflammation accumulation ACRprotein adduct Nε3formyl34dehydropiperidinolysine FDPLys human diabetic retina analysed Computational chemistry simulation performed predict 2HDPs passive permeability property potential systemic delivery 2HDP treatment effect blood glucose body weight water intake HbAsub1csub level BP diabetic rat p005 However protected retinal FDPLys accumulation p005 neurophysiological dysfunction preserving ERG waveform 3 6 month postdiabetes induction p005 p0001 scotopic awave bwave summed oscillatory potentials SDOCT imaging revealed 2HDP prevented retinal thinning 3 month p001 protected synaptic dysfunction evidenced preserved synaptophysin expression p001 p0001 inner outer plexiform layers respectively also prevented neurodegeneration maintaining retinal ganglion cells amacrine cells bipolar cells photoreceptors p005 p001 addition 2HDP prevented retinal arteriolar dilation p001 reduced microvascular permeability p005 attenuated microvascular damage indicated preserved pericyte number reduced acellular capillary formation p005 Mechanistically 2HDP inhibited microglial activation p005 suppressed upregulation proinflammatory molecule associated NVU dysfunction diabetic retina p005 p0001 preserved expression Müller cell glutamatehandling proteins glutamate aspartate transporter 1 glutamine synthetase p005 p001 FDPLys accumulation observed postmortem human retina individual type 2 diabetes p005 pattern similar rat model diabetes Molecular dynamic simulation showed neutral form 2HDP readily cross cell membranes enhanced permeation presence ACR highlighting potential systemic delivery 2HDP protects retinal NVU dysfunction diabetic rat reducing FDPLys accumulation preserving neuroretinal function preventing microvascular damage independent glycaemic control results combined evidence human diabetic retina molecular dynamic simulations support 2HDPs potential promising therapeutic agent DRD warranting preclinical clinical investigation",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40815371/",
        "source_type": "Global"
    },
    {
        "pmid": "40815364",
        "title": "Effects of Probiotics and Synbiotics Supplementation on Blood Pressure in Adults with Prediabetes and Type 2 Diabetes Mellitus: A Grade-Assessed Systematic Review and Dose-Response Meta-Analysis.",
        "abstract": "Prediabetes type 2 diabetes mellitus T2DM closely linked increased risk hypertension contributing significantly cardiovascular complications probiotic synbiotics shown potential benefit metabolic health specific effect blood pressure BP regulation population remain unclear study aim evaluate impact probiotic synbiotics supplementation BP control adult prediabetes T2DM addressing critical knowledge gap comprehensive search conducted online database inception January 2025 identify relevant randomized controlled trial RCTs Data extracted selected studies overall effect size determined using weighted mean difference WMD 95 confidence interval CIs randomeffects model statistical analysis carried using STATA software pooled analysis 17 RCTs 19 effect sizes 1281 participant 646 case 635 controls showed probiotic synbiotics supplementation led significantly reduction systolic BP WMD 327 mmHg 95 CI 538 116 p  0002 diastolic BP WMD 178 mmHg 95 CI 261 095 p  0001 GRADE assessment rated quality evidence SBP moderate due significant heterogeneity resulted serious inconsistency however major limitation identified comparison quality evidence DBP rated high metaanalysis suggests supplementation probiotic synbiotics effectively reduce BP adult prediabetes T2DM highlighting potential adjunctive strategy BP management Clinically incorporating supplement may offer safe accessible option support traditional therapy help reduce cardiovascular risk highrisk population",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40815364/",
        "source_type": "Global"
    },
    {
        "pmid": "40815299",
        "title": "Temperature induces a shift from insulin dihexamer to hexamer in collective dynamics.",
        "abstract": "Structures based xray diffraction data collected 23 288 295 Å resolution determined longacting dihexamer insulin three different temperatures ranging 100 300 K observed unitcell parameter insulin crystal 100 K change 200 K change likely due subtle repacking rhombohedral insulin crystal loss noncovalent interaction involving myristic acid bind two hexamers Computational analysis indicate allosteric residue fatty acidbinding residue insulin hexamers exhibit reduced collective dynamic interresidue coupling possibly resulting increased structural fluctuation due elevated thermal vibrations transition observed characteristic temperature 200 K potentially highlighting underlying alteration dynamic structure fatty acidsolvent interface dimer hexamers Combined computational analyses finding provide key insight thermal stability mechanisms crucial developing thermostable insulin formulation industrial applications",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40815299/",
        "source_type": "Global"
    },
    {
        "pmid": "40815238",
        "title": "Activated Protein C Suppresses Cardiomyocyte Senescence in Diabetic Cardiomyopathy via PAR1/PAR3-P85-CaMKIIδ Axis.",
        "abstract": "Diabetes exacerbates cardiomyocyte senescence leading accelerated decline cardiac function systemic level activated protein C aPC reduced correlated deterioration cardiac diastolic function diabetic cardiomyopathy DbCM underlying mechanism remained unclear aim identify role aPC ameliorating cardiomyocyte senescence DbCM highlighted aPC ameliorated cardiomyocyte senescence DbCM via PAR1PAR3P85CaMKIIδ axis genetic TMPP interventional PC injection diabetic mouse models finding could lead increased insight pathogenesis innovative therapeutic approach diabetic cardiomyopathy",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40815238/",
        "source_type": "Global"
    },
    {
        "pmid": "40815181",
        "title": "Safety Choice Drivers of the Coming Treatment Options for Non-Cirrhotic Metabolic Steatohepatitis.",
        "abstract": "Metabolic dysfunction associated steatohepatitis MASH formerly known NASH represents one leading cause chronic liver disease worldwide high prevalence driven insulin resistance obesity type 2 diabetes T2D associated cardiovascular disease main driver liver damage fat accumulation hepatocytes leading inflammation fibrosis development People MASH clinically significant fibrosis stage F2F3 at risk progressing cirrhosis hepatocellular carcinoma considered need treatment Metabolic driver MASH originating outside liver example adipose tissue gut genetic heterogeneity contribute making prevalent pathogenetic factor difficult dissect individual level scenario Food Drug Administrations conditional approval liverdirected thyroid hormone receptor beta agonist Resmetirom first pharmacological treatment MASH last March 2024 expected extension glucagonlike protein1 receptor agonist Semaglutide indication diabetes obesity MASH mark key milestone drug also evaluation European Medicines Agency proven efficacy compound clinical trial need balanced safety profile patient preferences investigate future trajectory possible us monotherapy combination examined available result clinical trial reallife studies Despite need await final result outcome study exclude possible challenge compounds safety profile external factor including reimbursement policy supply limitation may currently guide individual choice",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40815181/",
        "source_type": "Global"
    },
    {
        "pmid": "40815128",
        "title": "Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines for the Role of Medical Perioperative Management for Patients With Functioning Pituitary Adenomas.",
        "abstract": "Standardized perioperative management patient functioning pituitary adenoma important optimal medical surgical outcomes Review literature evaluate impact 1 postoperative fluid restriction sodium level check prevent delayed hyponatremia hospitalrelated readmissions 2 preoperative somatostatin analog SSA medical treatment patient growth hormonesecreting tumor effect surgical medical outcomes 3 immediate postoperative pituitary hormone testing patient adrenocorticotropic hormone ACTHsecreting tumor predict adrenal insufficiency disease remission Systematic literature search using Embase PubMed 1946 June 2021 total 1953 abstract identified review 124 study selected fulltext review 44 study included analyses Overall based predominantly level III evidence literature supported following 1 fluid restriction 10001500 mLday ∼7 postoperative days withwithout routine serum sodium check lower risk delayed hyponatremia hospitalrelated readmission 2 basal morning serum cortisol ±ACTH levels within immediate postoperative period ≤72 h patient ACTHsecreting tumor predict adrenal insufficiency disease remission Conversely perioperative treatment patient growth hormonesecreting tumor SSA recommended improve surgical medical outcomes Limited fluid restriction recommended patient transsphenoidal surgery without diabetes insipidus routine postoperative morning cortisol testing patient Cushing disease somatostatin presurgical treatment acromegalic patients",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40815128/",
        "source_type": "Global"
    },
    {
        "pmid": "40815122",
        "title": "GLP-1RA Semaglutide Delays the Progression of ADPKD Through Regulation of Glycolysis, Mitochondria Function and Ketosis.",
        "abstract": "Autosomal dominant polycystic kidney disease ADPKD genetic disease caused mutation PKD genes Glucagonlike peptide1 GLP1 receptor agonist GLP1RAs class medication mimic action hormone GLP1 conferring beneficial effect weight management metabolic conditions However whether GLP1RA play kidneyprotective action ADPKD remains unknown study define role mechanism one popular GLP1RA agonists Semaglutide ADPKD show expression GLP1R decreased Pkd1 mutant renal epithelial cell kidneys Treatment Semaglutide delay cyst growth aggressive longlasting Pkd1 mutant mouse models Treatment Semaglutide 1 decrease glucose uptake ATP generation glycolysis 2 deactivates PKDassociated signaling pathways including Rb S6 Stat3 resulting decrease cell proliferation 3 deactivates NFkB signaling pathways resulting decrease expression cytokine recruitment macrophages 4 normalizes mitochondrial morphology function 5 induces Pkd1 mutant renal epithelial cell death 6 induces ketosis characterized increase serum level betahydroxybutyrate BHB activation AMPK 7 alleviates renal fibrosis deactivation TGFb signaling Pkd1 mutant mouse kidneys study highlight potential GLP1R agonist novel therapeutic strategy ADPKD treatment",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40815122/",
        "source_type": "Global"
    },
    {
        "pmid": "40815068",
        "title": "Fully closed-loop control with ultra-rapid versus standard insulin lispro: A randomised crossover study simulating missed meal boluses.",
        "abstract": "Ultrarapid insulin lispro URIL associated faster insulin absorption earlier offset standard insulin lispro IL study evaluated whether URIL improves glucose control fully closedloop setting 8h period compared IL condition simulating missed meal bolus openlabel randomised crossover trial 18 adult type 1 diabetes using insulin pump therapy 12 females age 391 142 yrs HbA1c 579 87 mmolmol completed two 8h inpatient session 0900 1700 h Glucose level managed using CamAPS FX closedloop system either URIL IL random order Participants received standardised meal 1100 h without meal bolus primary endpoint percentage time range TIR 3910 mmolL based sensor glucose Data related 8h study period 17 participant analysed TIR numerically higher statistically significant URIL IL 493 156 vs 399 189 p  0072 lower time spent Level 1 10 mM 507 156 vs 595 191 p  0098 Level 2 hyperglycaemia 139 187 171 vs 279 198 p  0136 Similar trend observed 4h postmeal period Time hypoglycaemia low comparable period p  005 URIL fully closedloop setting showed clinically meaningful trend towards improved TIR reduced hyperglycaemia compared IL advancement fasteracting insulin needed alleviate burden premeal bolusing enhance fully closedloop performance future",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40815068/",
        "source_type": "Global"
    },
    {
        "pmid": "40815050",
        "title": "[Type 2 diabetes and binge eating disorder].",
        "abstract": "review find coexisting type 2 diabetes T2D binge eating disorder BED may significant individual societal cost due health socioeconomic consequences BED may worsen T2D management potentially raising HbA1c level complicating treatment ≤ 25 T2D patient BED yet research treatment limited Studies indicate T2D treatment trigger worsen binge eating due focus diet exercise weight Effective screening tailored evidencebased intervention needed dual diagnosis improve physical psychosocial health outcomes",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40815050/",
        "source_type": "Global"
    },
    {
        "pmid": "40814911",
        "title": "Metabolic Problems Among People With Treatment-Resistant Schizophrenia are Not Unique to Clozapine.",
        "abstract": "unclear whether treatment clozapine compared directly antipsychotics differentially associated metabolic problem among people treatmentresistant schizophrenia TRS evaluated prevalence diabetes dyslipidemia obesity hypertension parameter glucose lipids weight blood pressure people TRS managed clozapine nonclozapine antipsychotics Demographic clinical metabolic data patient TRS commenced clozapine 2006 2016 public hospital collected 2023 Participants divided clozapine discontinued clozapine antipsychotic data collected Metabolic disorder 2 group compared test χ2 test MannWhitney U test significance level set P005 One hundred six participant TRS treatment clozapine 41 antipsychotics participants mean age 443 SD 102 years 741 males Metabolic disorder dyslipidemia 456 obesity 374 diabetes 221 prevalent among people TRS However significant difference diabetes obesity hypertension parameter blood sugar lipid levels blood pressure clozapine nonclozapine cohorts dyslipidaemia significantly higher among managed clozapine 75 prescribed statins comprehensive approach addressing broad range risk factors rather solely focusing clozapine could beneficial evaluating treating metabolic problem among people TRS",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40814911/",
        "source_type": "Global"
    },
    {
        "pmid": "40814884",
        "title": "A Structure-activity Relationship (SAR) Insight for the Most Effective Oral Antidiabetic Compounds-A Current Review.",
        "abstract": "Diabetes mellitus chronic metabolic disorder pose significant global health challenge demanding continuous research effective treatments projection 629 million individual affected 2045 escalating healthcare costs need new antidiabetic medication urgent Current therapy often present limitations including undesirable side effect insufficient longterm efficacy review explores development oral antidiabetic drug OADs focusing structureactivity relationship SAR employed create established emerging class medications examine six major OAD classes biguanides sulfonylureas meglitinides thiazolidinediones DPP4 inhibitors SGLT2 inhibitors addition new promising class OAD namely metal complexes discussed review highlight crucial role synthetic chemistry advancing diabetes treatment improving patient outcomes",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40814884/",
        "source_type": "Global"
    },
    {
        "pmid": "40814845",
        "title": "Assessment of Thermal and Photolytic Stress Effects on the Stability of Primary Structure of Synthetic Liraglutide Using LC-HRMS/MS.",
        "abstract": "Liraglutide LGT synthetic glucagonlike peptide1 GLP1 analogue widely used treatment Type 2 diabetes obesity Due peptidebased nature prone degradation particularly improper storage handling conditions Environmental stressors heat light lead formation impurity may compromise quality safety drug study investigated impact thermal photolytic stress LGT stability using reversephase liquid chromatography coupled highresolution mass spectrometry LCHRMS method enabled separation identification characterization intact LGT degradation product DPs Ten impurity identified including four DPs reported far Further MSMS fragmentation analysis employed elucidate sequence LGT impurities pinpointing modification respective sites formation mechanism impurity also proposed providing critical insight degradation pathways study offer comprehensive analytical approach assessing stability peptide drugs contributing enhanced quality control safer pharmaceutical formulations",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40814845/",
        "source_type": "Global"
    },
    {
        "pmid": "40814817",
        "title": "Exploring potential barriers and facilitators to integrate tuberculosis, diabetes mellitus, and tobacco control programmes in India.",
        "abstract": "Cointegrating tuberculosis TB diabetes mellitus DM tobacco control TC programme India could help address triple burden diseases However limited information exists regarding feasibility determining factor integration explored potential barrier facilitator integrating TB DM TC programme Ambegaon Block Pune District Maharashtra Ballabgarh Block Faridabad District Haryana India conducted qualitative study based indepth interview health workers programme managers stakeholder involved TB DM TC programme implementation enrolled using purposive snowball sampling interview guide based World Health Organizations Health System Strengthening framework collected data November 2022 March 2023 analysed rapid analysis method interviewed 32 participants major challenge integration according participants perspectives relates level service delivery primarily attributed inadequate implementation programmes Themes emerged facilitator welldesigned programme robust guideline ample space infrastructure seen barrier included inadequate referral systems insufficient infrastructure limited resources shortage trained staff lack essential drug equipment impeded uptake coverage services finding highlight critical importance addressing barrier facilitator implementing programme India tackling triple burden TB DM TC multidimensional approach targeted strategy needed overcoming challenges Sensitising health system staff implementing feedback referral systems developing crossprogramme digital platform offer roadmap policymakers healthcare system managers",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40814817/",
        "source_type": "Global"
    },
    {
        "pmid": "40814743",
        "title": "Trends, Social Determinants, and Lifestyle Factors Associated With Comorbidity of Diabetes and Kidney Diseases Among Chinese Adults Aged ≥ 45 Years.",
        "abstract": "dual burden diabetes kidney disease pose growing public health challenge aging populations yet longitudinal trend modifiable determinant China remain understudied study aim track trend prevalence comorbidity diabetes kidney disease Chinese middleaged older adult 10year period 20112020 identify social determinant lifestyle factor associated comorbidity study utilized data five wave China Health Retirement Longitudinal Study CHARLS Temporal trend geographical distribution comorbidity diabetes kidney disease analyzed across survey years disaggregated sex residence geographical region Cox proportional hazard regression model employed explore association SDOH burden lifestyle factors risk comorbidity prevalence diabetes kidney disease comorbidity exhibited clear upward trend among Chinese adult aged ≥ 45 years increasing 060 2011 310 2020 Geographical analysis revealed significant regional disparities Northeast China highest prevalence throughout decade 476 2020 High SDOH burden associated increased risk comorbidity HR  124 95 CI  101152 Conversely maintaining good HR  038 95 CI  027054 moderate HR  074 95 CI  059091 lifestyle associated reduced risk rising prevalence significant regional disparity diabetes kidney disease comorbidity underscore urgent need targeted public health intervention China",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40814743/",
        "source_type": "Global"
    },
    {
        "pmid": "40814712",
        "title": "[Impact of critical care warning platform on the clinical prognosis of patients transferred from internal medical ward to intensive care unit: a real-world cohort study].",
        "abstract": "evaluate impact critical care warning platform CWP clinical outcome patient transferred internal medical ward intensive care unit ICU based realworld data retrospective cohort study conducted patient transferred internal medical ward ICU Zhongda Hospital Southeast University January 2022 October 2024 enrolled divided critical care warning group conventional treatment group based whether connected CWP patient critical care warning group connected CWP collected realtime vital sign treatment data platform automatically calculated severity scores generated individualized risk assessments triggered warning alerts allowing clinician adjust treatment plan accordingly patient conventional treatment group connected CWP relied conventional clinical judgment nursing measure treatment management Baseline characteristic gender age body mass index BMI admission type severity score illness underlying diseases disease type ICU admission primary clinical outcome inhospital mortality secondary clinical outcome ICU mortality length ICU stay total length hospital stay mechanical ventilation continuous renal replacement therapy CRRT status collected Multivariate Logistic regression used analyze impact CWP inhospital death subgroup analysis performed based different patient characteristics total 1 281 patient enrolled 768 critical care warning group 513 conventional treatment group Compared conventional treatment group proportion patient critical care warning group underlying disease diabetes malignancy transferred ICU due sepsis lowered however statistically significant difference baseline characteristic two groups Regarding primary clinical outcome inhospital mortality critical care warning group significantly lower conventional treatment group 176 135768 vs 257 132513 P  001 secondary clinical outcomes compared conventional treatment group patient critical care warning group significantly fewer day mechanical ventilation within 28 day days 2 1 6 vs 2 1 8 P  005 significantly shorter length ICU stay days 3 2 8 vs 4 2 10 P  001 significantly lower ICU mortality 151 116768 vs 214 110513 P  001 Multivariate Logistic regression analysis showed that adjusting age underlying diseases use CWP significantly associated reduction inhospital mortality among patient transferred internal medical ward ICU odds ratio OR  0670 95 confidence interval 95CI 05020894 P  0006 subgroup analysis revealed that among patient transferred ICU due sepsis use CWP significantly reduced inhospital mortality OR  0514 95CI 03670722 P  0001 patient aged ≥ 70 year old OR  0587 95CI 04150831 P  0003 underlying disease malignancy OR  0124 95CI 00460330 P  0001 CWP also showed significant protective effect inhospital prognosis use CWP significantly associated reduction inhospital mortality among patient transferred internal medical ward ICU demonstrating potential assessing deterioration hospitalized patients",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40814712/",
        "source_type": "Global"
    },
    {
        "pmid": "40814629",
        "title": "Assessing Social Participation Among Kidney Transplant Recipients Using PROMIS Computer Adaptive Testing.",
        "abstract": "Social participation valued aspect quality life among kidney transplant recipients however validated measure exist assess it study aimed explore reliability validity PatientReported Outcomes Measurement Information System PROMIS Ability Participate Social Roles Activities PROMISSP administered computer adaptive test CAT among kidney transplant recipients crosssectional study involving convenience sample adult recipient Toronto Canada Participants completed PROMISSP CAT legacy measure social participation electronic data capture platform Reliability PROMISSP CAT determined using standard error measurement SEM testretest reliability using intraclass correlation coefficient Convergent validity assessed calculating Spearmans correlation PROMISSP CAT legacy measures construct validity assessed using known group comparisons recruited 284 participant mean SD age 53 14 year median 55 year since kidney transplantation 61 male 53 White 30 diabetes mean SD PROMIS Tscore 51 9 Reliability iri  093 testretest reliability intraclass correlation coefficient  097 PROMISSP CAT excellent Strong correlation observed PROMISSP CAT social difficulty inventory SDI rho  065 SDI everyday living rho  068 EuroQol5 Dimensions5 Levels EQ5D5L usual activities rho  066 PROMISSP CAT score significantly different known group expected direction result support validity reliability PROMISSP CAT among kidney transplant recipients suggest tool used identify recipient restricted social participation",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40814629/",
        "source_type": "Global"
    },
    {
        "pmid": "40814615",
        "title": "Kidney Disease: Improving Global Outcomes Summit Recommendations on Implementation of Diabetes Management in CKD: From Primary to Data-Driven Collaborative Care.",
        "abstract": "Type 2 diabetes chronic kidney disease CKD preventable treatable silent progressive clinical course call structured assessment timely feedback patient care provider activating decisionmaking Apart CKD patient diabetes complication affecting multiple organs notably cardiovascular system eyes feet International practice guideline recommend annual assessment eyes feet blood urine detect silent complication measure cardiovascularkidneymetabolic CKM risk factor ensure early intervention including treatment multiple target use organprotective drugs report highlight barrier gap implementation practice guideline managing diabetes CKD proposed solution overcome barriers improving practice environment workflow nurse trained perform protocolguided evaluation medical supervision systematic data collection enables physician make timely decisions including drug prescription referral specialist promote collaborative care whereas nurse use personalized data empower patient selfmanagement improve health literacy ongoing data collection form register align payers providers patient delivering datadriven valuebased care creation realworld evidence verify treatment effectiveness identify care gap providing onthejob training accompanied biobank ongoing collection analysis multidimensional data refine diagnosis classification prognosis treatment pursuit precision medicine",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40814615/",
        "source_type": "Global"
    },
    {
        "pmid": "40814544",
        "title": "Quality of life in patients with diabetes in a Rural Health and Training Centre.",
        "abstract": "Diabetes one chronic noncommunicable disease degrade quality life assess quality life among people aged 30 60 year diabetes attending Rural Health Training Centre RHTC crosssectional study conducted RHTC medical college crosssectional study conducted RHTC medical college assess quality life QOL diabetic patient aged 30 60 year attending diabetic clinic IEC approval obtained Informed consent obtained data collected interviewing 157 participant semistructured questionnaire QOL assessed using World Health Organizations Quality Life Questionnaire  short version WHOQOLBREF entire collected data first added Microsoft Excel Statistical Package Social Sciences SPSS Windows version 160 used data analysis interview conducted among 157 patients majority females literate married unemployed mean ± SD physical domain 5667 ± 1373 psychological domain score 6236 ± 958 social domain score 5205 ± 1640 environmental domain score 6088 ± 897 study show impact diabetes mellitus QOL improvement needed proper treatment regimen good control blood sugar improve overall QOL diabetic patients",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40814544/",
        "source_type": "Global"
    },
    {
        "pmid": "40814543",
        "title": "Invasive fungal infections and the management in immunocompromised conditions.",
        "abstract": "Invasive fungal infections opportunistic lead severe disease immunocompromised host increase morbidity mortality common causative agent include Candida Mucorales Aspergillus Cryptococcus Pneumocystis species common risk factor associated invasive fungal infection uncontrolled diabetes mellitus leading hyperglycemia neutropenia immunosuppressive treatment like corticosteroids primary secondary immunodeficiency disorders especially acquired immunodeficiency syndrome Various molecular therapeutic agent used targeted therapy also associated increase opportunistic infection involve many signaling pathway related immunity pathogens Prompt diagnosis disease caused invasive fungal infection necessary immunosuppression increase risk fatality treatment initiated immediately based susceptibility recommendations",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40814543/",
        "source_type": "Global"
    },
    {
        "pmid": "40814519",
        "title": "Drug utilization pattern and cost analysis of antidiabetic drugs among type 2 diabetic patients at a teaching hospital in South India: A prospective observational study.",
        "abstract": "Type 2 diabetes mellitus T2DM significantly contributes global burden chronic diseases Rational prescribing complete documentation essential optimizing therapeutic outcome ensuring continuity care evaluate drug prescribing pattern using World Health Organization WHO core prescribing indicators assess completeness prescription documentation analyse cost drug therapy among type 2 diabetic patient attending teaching hospital South India conducted crosssectional study among type 2 diabetic patient visiting Department General Medicine audited completeness prescription based presence superscription inscription subscription components Prescribing trend analysed using drug use indicators total cost drug per prescription proportion attributed antidiabetic drug calculated average number drug per prescription 45 percentage drug prescribed generic name 6803 percentage patient injection prescribed 583 Percentage patient prescribed antibiotic 212 997 drug prescribed NLEM list study highlight area improvement including use multiple medications relatively high rate injectable prescriptions opportunity enhance generic prescribing among diabetic patient teaching hospital India Multidisciplinary collaboration essential rational costeffective medication use improved healthcare outcomes",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40814519/",
        "source_type": "Global"
    },
    {
        "pmid": "40814493",
        "title": "Digital foundations for health equity: Rethinking primary care through the Ayushman Bharat digital mission.",
        "abstract": "Ayushman Bharat Digital Mission ABDM mark pivotal step Indias journey toward unified citizencentric health ecosystem integration primary healthcare PHCthe accessible foundational tier service deliveryoffers transformative potential enabling unique digital health IDs interoperable health records consentbased data sharing ABDM promise improve continuity care empower frontline health workers support longterm management chronic disease community level However groundlevel implementation face challenge poor infrastructure limited digital literacy workflow resistance concern around data privacy viewpoint argues technology central true value emerge inclusive design local ownership sustained investment human capacity ABDM thoughtfully implemented redefine role PHCnot merely first point contact digitally enabled personcentered platform equitable care delivery",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40814493/",
        "source_type": "Global"
    },
    {
        "pmid": "40814491",
        "title": "Retinal nerve fiber layer thickness and macular ganglion cell analysis in gestational diabetes mellitus in various trimesters-A case series study.",
        "abstract": "Gestational diabetes mellitus GDM glucose intolerance state induced pregnancy condition may resolve persist even pregnancy period documented four case GDM different trimester puerperium Optical coherence tomography OCT imaging case revealed retinal nerve fiber layer RNFL ganglion cell layer GCL GCL layer thinned indicating neuronal degeneration GDM result imply GDM retinal neurodegeneration occurs developing diabetic retinopathy pregnancy also puerperium mandatory carry routine evaluation retina help OCT GDM patient detect early neurodegenerative changes measuring layers clinician observe progression diabetic retinopathy determine benefit treatment strategies",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40814491/",
        "source_type": "Global"
    },
    {
        "pmid": "40814473",
        "title": "To study effects of metformin on thyroid functions in type-2 diabetes mellitus in patients attending OPD at Government Medical College, Bidar.",
        "abstract": "Metformin one used diabetes treating agent proved effective wide spectrum efficacy safety well agent work different spot diabetes pathogenesis paradigm Recently reported metformin able interfere thyroid hormone profile decrease serum level thyrotropin TSH subnormal level hypothyroid patient stable levothyroxine LT4 treatment study compare effect metformin nonmetformin composed treatment type2 diabetes mellitus thyroid functions Comparative observational study conducted among diabetic patient taking metformin study taking antidiabetic metformin control group analysed thyroid profile TSH fT3 fT4 Total 70 patient including group tertiary care teaching hospital enrolled study taking informed verbal consent present study demonstrates study groups fT3 fT4 level lower control group diabetic patient nonmetformin medication statistically higher TSH 205 ± 015 mIUmL vs 235 ± 018 mIUmL level taking metformin Thyroidstimulating hormone TSH level may somewhat decreased metformin Thyroid function monitoring crucial diabetic patient using metformin particularly already thyroid problems",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40814473/",
        "source_type": "Global"
    },
    {
        "pmid": "40814472",
        "title": "Risk factors for COVID-19-associated mucormycosis (CAM): A case-control study.",
        "abstract": "Mucormycosis rare serious fungal infection surged second wave COVID19 pandemic Despite various proposed causative factors published data limited study aimed identify risk factor COVID19associated mucormycosis casecontrol study conducted Nagpur district Cases recruited suspected confirmed mucormycosis case reported district health authorities Controls household member COVID19 develop mucormycosis Predisposing treatmentrelated factor analyzed Analysis revealed significant association mucormycosis diabetes mellitus OR108 CI111036 corticosteroid use OR976 CI3229271 Factors humidifier use mask usage show significant association Optimal use oxygen corticosteroid crucial particularly diabetic COVID19 patients prevent mucormycosis",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40814472/",
        "source_type": "Global"
    },
    {
        "pmid": "40814339",
        "title": "Palmitic acid and palmitoylation in cancer: Understanding, insights, and challenges.",
        "abstract": "Nutrients dietary food provide energy building blocks also play critical role modulating diverse pathophysiological functions achieve these part accelerating cell signaling transduction process via modulating various type protein posttranslational modification PTMs Notably accumulating evidence identified palmitic acid PA major component highfat diets significant contributor various human disorders including diabetes cancer Hence understanding role PA involvement protein palmitoylation key PTM crucial uncovering mechanism underlying disease exploring potential clinical application cancer therapy review comprehensively summarizes recent advance understanding PA homeostasis palmitoylation tumorigenesis Specifically highlight connection palmitoylation key process oncogenic signaling pathways cell death mechanisms innate immune responses tumor microenvironment review also emphasizes potential therapeutic strategies including targeting PA homeostasis palmitoylationassociated processes specific palmitoylated protein cancer treatment Finally challenge field regulation PA homeostasis dynamic detection targeting palmitoylation discussed underscoring need research address critical issues",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40814339/",
        "source_type": "Global"
    },
    {
        "pmid": "40814224",
        "title": "CGM Data Analysis 2.0: Functional Data Pattern Recognition and Artificial Intelligence Applications.",
        "abstract": "New method continuous glucose monitoring CGM data analysis emerging valuable interpreting CGM pattern underlying metabolic physiology new method use functional data analysis artificial intelligence AI including machine learning ML Compared traditional metric evaluating CGM tracing result CGM Data Analysis 10 new methods refer CGM Data Analysis 20 provide detailed understanding glucose fluctuation trend enable personalized effective diabetes management strategy translated practical clinical solutions",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40814224/",
        "source_type": "Global"
    },
    {
        "pmid": "40814104",
        "title": "Unveiling the UHR threshold in American adult: a new biomarker for early diabetes detection from NHANES study.",
        "abstract": "study examines association serum uric acid highdensity lipoprotein cholesterol ratio UHR biomarker risk prediabetes diabetes relationship remains underresearched provide insight diabetes prevention study utilized data 13975 American participant National Health Nutrition Examination Survey 20112018 Logistic regression models restricted cubic spline RCS analysis subgroup analysis employed examine association UHR prediabetesdiabetes median UHR 104 6382 457 case prediabetes diabetes detected higher UHR associated increased risk prediabetes diabetes showing 39 increased risk per standard deviation increment OR 139 95 CI 133146 Consistent result observed UHR categorized Participants highest UHR quartile exhibited significantly higher risk prediabetesdiabetes lowest quartile OR 263 95 CI 230301 RCS analysis revealed nonlinear association threshold value 1250 threshold higher UHR significantly associated prediabetesdiabetes OR 117 95 CI 115119 threshold association significant Subgroup analysis highlighted marked gender disparity woman exhibiting stronger association research found positive link UHR prediabetes diabetes prevalence nonlinear relationship noted significant association observed UHR threshold 1250 especially females",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40814104/",
        "source_type": "Global"
    },
    {
        "pmid": "40814089",
        "title": "Management and safety of same day bilateral intravitreal anti-VEGF injections in a treat-and-extend regimen.",
        "abstract": "Antivascular endothelial growth factor VEGF intravitreal injection treatment IVTs gold standard various neovascular retinal diseases including neovascular agerelated macular degeneration nAMD diabetic macular edema DME macular edema due retinal vein occlusion RVO day bilateral IVTs commonly performed offlabel worldwide reduce patient burden despite limited safety data study evaluates safety management bilateral day antiVEGF injection within treatandextend regimen TER proposes clinical guideline coordination bilateral treatment retrospective observational study analysed electronic health record 428 included patient treated bilaterally ranibizumab 05mg aflibercept 2mg VISTA Augenklinik Binningen Switzerland 2015 2019 Patients included bilateral macular edema due nAMD DME RVO received least two cycle day bilateral antiVEGF injection within TER Treatment coordination followed one four strategies Equal TER Coordinated TER Mixed TER pro nata PRN Asynchronous TER Unilateral IVTs also recorded period patient cohort Ocular systemic adverse event AEs compared unilateral bilateral injection using Fishers exact test total 15825 antiVEGF injection administered 4766 bilateral day injection Formula see text 6293 unilateral injections Treatment interval synchronised according visual acuity potential disease activity treatment regime bilateral IVTs established provided manuscript frequently reported ocular AEs conjunctival haemorrhage sicca symptoms Systemic AEs cerebrovascular cardiovascular event rare significant difference bilateral unilateral injections Bilateral day intravitreal antiVEGF injection within TER regimen appear safe significant increase ocular systemic AEs compared unilateral treatment Coordinating bilateral IVTs using clinical guideline presented study may reduce treatment visits ease patient burden improve compliance Larger prospective study needed confirm safety support standardised guideline bilateral IVTs",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40814089/",
        "source_type": "Global"
    },
    {
        "pmid": "40814082",
        "title": "Real-world analysis of characteristics and guideline adherence of antiplatelet drugs prescriptions among patients with coronary artery disease and its comorbidities: a cross-sectional study.",
        "abstract": "identify characteristic antiplatelet drug APD prescription based regional largescale outpatient database Shanghai China compare practical usage APDs respective clinical guideline patient coronary artery disease CAD China Outpatient electronic healthcare record extracted 20 medical institution Shanghai January 2020 October 2021 Outpatient APD prescription among CAD patient comorbidity status analyzed χsup2sup test guideline adherence specific APD regimen also evaluated 1532972 outpatient visits 284400 1855 involved APDs APD likely utilized patient recent ACS 2760 χsup2sup  888475 P  0001 CCS n  280025 1846 χsup2sup  881045 P  0001 coexisting hyperlipidemia n  22387 2907 χsup2sup  5938871 P  0001 diabetes n  14087 2292 χsup2sup  808226 P  0001 hypertension n  40193 2211 χsup2sup  1724758 P  0001 atherosclerosis n  439 2124 χsup2sup  9885 P  0002 Recent ACS patient CCS patient comorbidities prone treated dual aspirinclopidogrel therapy P  0001 Dual aspirinticagrelor therapy second common choice CCS patient n  210230 1386 χsup2sup  9274 P  0002 followed aspirin n  203551 1342 χsup2sup  59267 P  0001 clopidogrel n  75702 499 χsup2sup  4276533 P  0001 ticagrelor monotherapy n  794 052 χsup2sup  4276533 P  0001 Among recent ACS patients clopidogrel monotherapy second frequently used n  2624 1650 χsup2sup  4304044 P  0001 followed dual aspirinticagrelor therapy n  2071 1303 χsup2sup  9101 P  0003 aspirin monotherapy n  1082 1133 χsup2sup  58818 P  0001 ticagrelor monotherapy n  354 223 χsup2sup  84768 P  0001 rationality analysis showed CCS rating 3 representing average recent ACS CAD reflux esophagitis APD prescription consistent guideline rating  2 proportion APD prescription CAD outpatient lower expected rationality analysis revealed CCS recent ACS patient showed suboptimal guideline adherence realworld APD prescriptions especially patient comorbid reflux esophagitis gap indicated realworld prescription activity disease receive attention",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40814082/",
        "source_type": "Global"
    },
    {
        "pmid": "40814081",
        "title": "2025 ADS/ANZCA/GESA/NACOS clinical practice recommendations on the peri-procedural use of GLP-1/GIP receptor agonists.",
        "abstract": "Glucagonlike peptide1 receptor agonist GLP1RAs widely used treatment type 2 diabetes andor obesity physiological action endogenous GLP1 synthetic GLP1RAs include inhibition gastric emptying periprocedural implication due potential increased risk retained gastric content may result pulmonary aspiration need local evidencebased guideline best manage patient GLP1RAs dual GLP1 glucosedependent insulinotropic polypeptide receptor coagonists GLP1GIPRAs presenting surgical medical procedure requiring sedation anaesthesia panel expert formed consider periprocedural implication GLP1RA GLP1GIPRA use establish best practice recommendation based current evidenceWe recommend patient asked glucagonlike peptide1 receptor agonist GLP1RA dual GLP1 glucosedependent insulinotropic polypeptide receptor coagonist GLP1GIPRA use prior anaesthesia sedation surgical endoscopic procedure informed benefit risks also recommend GLP1RAs GLP1GIPRAs continued periprocedural period Preprocedural diet modification 24h clear fluid diet followed standard 6h fasting recommended patient receiving GLP1RAs GLP1GIPRAs patient completed unable 24h liquid diet risk stratification using gastric ultrasound minimally sedated gastroscopy assess gastric content recommended use intravenous erythromycin cannot currently recommend using absence gastrointestinal symptom risk stratification recommend adequate cessation period GLP1RAs GLP1GIPRAs ensure gastric emptying returned baseline levels clinical guideline developed multiple professional bodies outline current best practice recommendation patient taking GLP1RAs combined GLP1GIPRAs require general anaesthesia sedation andor endoscopic procedures guide provides structure Australian New Zealand primary health practitioners gastroenterologists surgeons endocrinologists anaesthetist perioperative physician support clinical decision patients",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40814081/",
        "source_type": "Global"
    },
    {
        "pmid": "40814048",
        "title": "Differences in the relationship between medication adherence and payer medical costs across three quality measures: results of a cohort study among medicare advantage beneficiaries.",
        "abstract": "considerable evidence medication nonadherence associated higher healthcare costs Payers provider often target adherence quality measure intervention impact may depend medication study sought assess difference relationship medication adherence medical ie nonpharmacy cost across three quality measure Medicare Advantage sample observational study conducted among cohort Medicare Advantage beneficiary using 201819 Optum’s deidentified Clinformaticssup®sup Data Mart Database Cohort assignment based inclusion one three Pharmacy Quality Alliance’s adherence measure 1 reninangiotensinsystem antagonists 2 statin 3 diabetes medications Medication adherence measured year 1 payer medical cost measured year 2 Generalized linear modeling Gamma distribution log link interaction term coefficient contrast used assess relationship adherence subsequent payer medical costs evaluate difference relationship across three measures Analyses adjusted sociodemographic clinical prescriptionrelated insurancerelated variables singlemeasure cohort included 1001316 beneficiaries threemeasure cohort consisted 284137 beneficiaries negative relationship ipi  00001 adherence payer medical cost medication classes association stronger diabetes medication 09808 ipi  00001 followed reninangiotensinsystem antagonist 09874 ipi  00001 statin medication 09919 ipi  00001 singlemeasure cohort finding similar among beneficiary using three medication classes Better adherence associated lower payer medical cost across several therapeutic areas providing additional evidence importance adherence managing health care costs relationship adherence subsequent year medical cost appears stronger diabetes medication relative reninangiotensinsystem antagonist statins research may explore intervention increase adherence diabetes medication improve diabetes management online version contains supplementary material available 101186s12913025133312",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40814048/",
        "source_type": "Global"
    },
    {
        "pmid": "40814000",
        "title": "Deep phenotyping of a modified diabetic cardiomyopathy mouse model which reflects clinical disease progression.",
        "abstract": "Diabetic cardiomyopathy DbCM progressive disease common complication metabolic diabetes characterised onset cardiac structural functional impairment lead direct development clinical heart failure HF predispose hypertensiveischaemic stress DbCM complex disease involves several metabolic pathogenic factors characterised established highfat dietstreptozotocin HFDSTZinduced DbCM model incorporating typical feature human disease determine suitability preclinical evaluation novel therapeutic prior advancement human trials Male C57BL6J mouse randomised HFD singledose STZ 100 mgkg control diet CD vehicle HFDSTZ mouse developed type 2 diabetes mellitus T2DM reflected high fasting blood glucose HbA1c levels reduced βcell function increased insulin resistance without systolic blood pressure alteration Furthermore HFDSTZ mouse displayed progressive diastolic dysfunction evidenced decreased MV EA ratio together elevated chronic left ventricular LV filling pressure parameters measured left atrial LA area LA volume compared controls parallel LV hypertrophy fibrosis Monocyte trafficking diabetic heart identified singlenuclei RNA sequencing analysis revealed interferonα response DbCM mice whilst plasma proteomics confirmed involvement inflammatory process elevated plasma Creactive protein DbCM progression Taken together HFDSTZinduced DbCM model exhibit unique DbCM preclinical phenotype reflecting triplehit human DbCM feature comprising 1 T2DM insulin resistance 2 progressive diastolic dysfunction LV remodelling 3 metabolic inflammation improved HFDSTZinduced DbCM model support clinically relevant research DbCM progression early stage cardiac dysfunction remodelling basis translational investigation",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40814000/",
        "source_type": "Global"
    },
    {
        "pmid": "40813999",
        "title": "Therapeutic effects of crocin in alleviating diabetic neuropathy: a preliminary randomized triple-blind placebo-controlled trial.",
        "abstract": "Diabetic neuropathy prevalent debilitating complication type 2 diabetes resulting functional impairments Crocin bioactive constituent saffron Crocus sativus long utilized traditional medicine potential therapeutic effects study aimed evaluate efficacy Crocin alleviating neuropathic symptom patient type 2 diabetes tripleblind randomized placebocontrolled clinical trial patient type 2 diabetes confirmed peripheral neuropathy randomly assigned receive either 15 mgday Crocin matching placebo 12 weeks Neuropathic symptom assessed using Total Symptom Score TSS Visual Analog Scale VAS Michigan Neuropathy Screening Instrument MNSI baseline 3week intervals Fortytwo patient completed study 21 participant group week 9 Crocin group exhibited significantly lower mean TSS 51 ± 139 compared placebo group 66 ± 100 P  0005 Similarly VAS scores reflecting pain intensity significantly reduced Crocin group week 6 9 P  0019 MNSI score week 9 also favored Crocin group 57 ± 11 vs 68 ± 09 P  003 Crocin may offer promising therapeutic benefit reducing pain neuropathic symptom patient type 2 diabetes neuroprotective antioxidant antihyperglycemic property may contribute effects finding support potential beneficial effect crocin management diabetic neuropathy largescale robust clinical trial warranted validate results httpsirctir IRCT20190810044500N8 Registration date 01012021",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40813999/",
        "source_type": "Global"
    },
    {
        "pmid": "40813857",
        "title": "The effect of turmeric/curcumin supplementation on anthropometric indices in subjects with prediabetes and type 2 diabetes mellitus: A GRADE-assessed systematic review and dose-response meta-analysis of randomized controlled trials.",
        "abstract": "effective management diabetes prevalent metabolic condition globally relies paying close attention anthropometric measurements recent year seen growing interest researching potential antiobesity property turmericcurcumin systematic review doseresponse metaanalysis randomized controlled trials impact turmericcurcumin supplementation anthropometric index individual prediabetes type 2 diabetes mellitus T2DM assessed PubMed Cochrane Library Web Science Scopus Google Scholar searched identify relevant record published 1 January 1990 1 June 2024 Randomeffects metaanalysis performed evaluate weighted mean difference WMD 95 confidence interval CI pvalue ≤ 005 indicating statistical significance Grading Recommendations Assessment Development Evaluation GRADE used assess certainty evidence Twenty randomized controlled trial RCTs included metaanalysis Pooled analysis displayed supplementation turmericcurcumin significantly decreased body weight WMD 19 kg 95 CI 29 09 P ≤ 0001 GRADE  low waist circumference WMD 19 cm 95 CI 35 02 P  0024 GRADE  low fat mass WMD 29 95 CI 56 01 P  0041 GRADE  low hip circumference WMD 10 cm 95 CI 12 08 P ≤ 0001 GRADE  moderate effect body mass index waisttohip ratio people T2DM individual prediabetes body weight WMD 25 kg 95 CI 48 02 P  0037 GRADE  moderate waist circumference WMD 29 cm 95 CI 53 06 P  0015 GRADE  moderate significantly lower turmericcurcumin supplementtreated group untreated counterparts study found turmericcurcumin beneficial effect obesity indicators could contribute weight management individual prediabetes T2DM Systematic Review Registration study registered PROSPERO CRD42023440612",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40813857/",
        "source_type": "Global"
    },
    {
        "pmid": "40813845",
        "title": "A qualitative analysis of family experiences across diabetes-specific family functioning types during a family-focused intervention for adults with type 2 diabetes.",
        "abstract": "Numerous dimension family involvement important chronic illness management recently developed validated typology diabetesspecific family functioning organizes dimension four meaningful type Collaborative  Helpful Critically Involved Satisfied Low Involvement Want Involvement type represent pattern association across dimension family involvement synthesize multiple dimension functioning usable categories current study two primary aims first use qualitative data enhance quantitative understanding types second describe qualitatively participants experience family 9 month familyfocused intervention and 6 month followup based diabetesspecific family functioning type enrollment Adults type 2 diabetes T2D participated FamilyFriend Activation Motivate Selfcare FAMS familyfocused selfcare support intervention eligible recruited 77 participant across type participate semistructured interview completion followup found consistency across type difference types Regardless type harmful family involvement described adult T2D hesitant label such Communication diabetes health increased FAMS topic varied across types Adults T2D received support family across time though preference emotional instrumental support varied across types study qualitatively validated typology tool paving way future use intervention tailoring",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40813845/",
        "source_type": "Global"
    },
    {
        "pmid": "40813684",
        "title": "Carotenoid and peptide supplementation from Caulerpa sp. (sea grapes) extract mitigate metabolic syndrome in cholesterol-enriched diet rats via modulation of gut microbiota.",
        "abstract": "Metabolic syndrome MetS multifactorial disorder characterized obesity dyslipidemia insulin resistance hypertension increasing risk cardiovascular disease type 2 diabetes mellitus T2DM Recent evidence suggests gut microbiome dysbiosis play significant role MetS pathogenesis Functional food enriched bioactive compounds particularly derived marine sources emerged promising interventions study aimed evaluate effect carotenoid peptide supplementation iCaulerpa spi sea grapes extract metabolic syndrome gut microbiome modulation cholesterolfatenriched diet CFED rats randomized preclinical trial conducted using CFEDfed rats supplemented carotenoid peptide extract iCaulerpa spi Metabolic parameters lipid profiles enzymatic activities inflammatory biomarkers assessed Additionally gut microbiota composition analyzed using highthroughput sequencing techniques Supplementation iCaulerpa spi extract significantly improved metabolic markers including reduction body weight gain triglycerides total cholesterol lowdensity lipoprotein LDL blood glucose levels increasing highdensity lipoprotein HDL ipi  005 Enzymatic analysis revealed suppression key metabolic enzymes αglucosidase lipase suggesting potential regulatory effect lipid carbohydrate metabolism Moreover gut microbiome analysis indicated increased microbial diversity favorable shift bacterial taxa Specifically iFaecalibacteriumi iLactobacillusi known antiinflammatory metabolic benefits enriched iOscillospirai associated metabolic disorders showed decline microbial change suggest potential role iCaulerpa spi modulating gut health systemic metabolism finding demonstrate carotenoid peptide extract iCaulerpa spi effectively mitigate metabolic syndrome metabolic regulation gut microbiome modulation antiinflammatory mechanisms study highlight iCaulerpa spi potential functional food MetS management paving way future clinical applications applicable Image see text",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40813684/",
        "source_type": "Global"
    },
    {
        "pmid": "40813683",
        "title": "Leonurine (SCM-198) exerts protective effects on pancreatic β-cells in type 1 diabetes by modulating the Bax/Bcl-2/Caspase-3 signaling pathway.",
        "abstract": "Type 1 diabetes mellitus T1DM disease marked insulin deficiency hyperglycemia resulting destruction pancreatic βcells progression T1DM significantly influenced oxidative stress apoptosis Natural compound highly effective treatment T1DM multiple targets natural compound leonurine SCM198 possesses antiinflammatory antioxidant antiapoptotic properties However potential effect SCM198 treatment T1DM studied research aim explore therapeutic efficacy SCM198 context T1DM integration network pharmacology molecular docking analyses vitro vivo experimental validation study used pharmacokinetics explore druggability SCM198 mechanism SCM198 exerts effect T1DM explored using network pharmacology approach Subsequently molecular docking simulation employed investigate binding affinity core gene involved SCM198 treatment T1DM established mouse model streptozotocin STZinduced T1DM vivo evaluated therapeutic effect SCM198 T1DM blood glucose measurement pathology biochemical analysis formalized core pathway SCM198 regulation using STZdamaged Min6 cell vitro finding showed SCM198 obeys Lipinski’s rule five exhibit desirable absorption distribution metabolism excretion toxicity ADMET profiles core target significantly enriched apoptosis pathway Molecular docking analysis revealed Cysteineaspartic Acid Protease 3 CASP3 Tumor necrosis factor TNF Matrix metallopeptidase 9 MMP9 exhibited strong binding affinity SCM198 vivo experiments SCM198 could reduce fasting blood glucose FBG area glucose curve blood lipid liver function oxidative stress level T1DM model mice also effectively improve histopathological change pancreas aorta demonstrated SCM198 could protect Min6 cell apoptosis modulating Bcl2associated X Protein BaxBcell Lymphoma 2 Bcl2Caspase3 signaling cascade present study demonstrated SCM198 exerts protective effect pancreatic βcells T1DM attenuating apoptosis inhibiting BaxBcl2Caspase3 signaling pathway Therefore SCM198 hold great promise potential therapeutic candidate T1DM online version contains supplementary material available 101186s12906025050511",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40813683/",
        "source_type": "Global"
    },
    {
        "pmid": "40813549",
        "title": "Correction: Enhancing Diabetes Management Through Personality Assessment: A Pilot Study.",
        "abstract": "",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40813549/",
        "source_type": "Global"
    },
    {
        "pmid": "40813485",
        "title": "Increased plasma levels of erythropoietin after renal denervation in patients with resistant hypertension.",
        "abstract": "Erythropoietin Epo play crucial role formation maturation erythrocyte produced primarily peritubular cell renal cortex Previous study suggest renal sympathetic nerve activity RSNA may influence Epo regulation Catheterbased renal denervation RDN shown reduce renal noradrenaline spillover blood pressure patient resistant hypertension therefore aimed investigate whether RDN influence Epo levels 33 patient resistant hypertension age 61 ± 12 y baseline office blood pressure BP 165 ± 1685 ± 18 mmHg despite treatment average 49 ± 17 antihypertensive medications underwent bilateral RDN Plasma level Epo office blood pressure 24 h ambulatory blood pressure monitoring ABPM muscle sympathetic nerve activity MSNA renal function haemoglobin measured procedure 3 month followup Antihypertensive medication changed first 3 month RDN Office blood pressure reduced 15 ± 195 ± 12 mmHg 3 month denervation p  0001 systolic BP p  0033 diastolic BP 24hmean systolic diastolic BP also reduced from 145 ± 16 140 ± 18 mmHg p  0036 80 ± 11 77 ± 12 mmHg p  0024 respectively haemoglobin level remained unchanged significant increase plasma Epo level observed 3 month RDN 781 ± 368 versus 988 ± 506 mIUmL p  0025 Changes Epo level correlated baseline MSNA r  0580 p  0004 burst frequency r  0471 p  0023 burst incidence increase Epo pronounced patient high baseline MSNA RDNinduced change MSNA tended correlate inversely change Epo level r  0402 p  0064 finding suggest RDN associated increased plasma level Epo absence change haemoglobin effect possibly mediated via reduction sympathetic nerve activity",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40813485/",
        "source_type": "Global"
    },
    {
        "pmid": "40813411",
        "title": "In Silico evaluation of phytoconstituents from Carica Papaya and its anti-hyperglycemic activities on high sucrose-induced oxidative stress in Drosophila melanogaster.",
        "abstract": "Oxidative stress play key role development metabolic disorders diabetes study investigated phytoconstituents present Carica papaya AECP using silico model antihyperglycemic activity high sucroseinduced oxidative stress Drosophila melanogaster silico molecular docking performed analyze binding potential AECPs bioactive compound key diabetes targets Flies fed diet containing 30 sucrose induce oxidative stress followed administration AECP dos 50 100 mgkg five days Biochemical assay assessed glucose total thiols catalase glutathione Stransferase GST nitric oxide silico analysis revealed carpaine myricetin 3rhamnoside orientin 7Orhamnoside quercetin AECP exhibited strong binding potential key diabetes target alphaamylase betaglucosidase dipeptidyl peptidase 4 PPARG SGLT2 fruit flies sucrosediet significantly p  005 reduced total thiol level catalase GST activity increasing glucose nitric oxide levels AECP dosedependent manner significantly p  005 reversed changes demonstrating antioxidant possible antihyperglycemic properties finding suggest AECP may potential therapeutic agent mitigating oxidative stress support potential use managing diabetes",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40813411/",
        "source_type": "Global"
    },
    {
        "pmid": "40813151",
        "title": "Kidney failure risk equation (KFRE), A risk-based triage for nephrology referrals: A mixed-methods study at pre-implementation phase among healthcare providers.",
        "abstract": "Chronic kidney disease CKD pose significant health challenge globally limited understanding challenge opportunity enhance CKD management perspective healthcare provider HCPs involved direct care patient CKD integrate riskbased triage nephrology referrals namely kidney failure risk equation KFRE explored HCPs perspective facilitator barrier CKD management implementation KFRE used mixed method approach explore HCPs perspective 1 facilitator barrier CKD management 2 perceived benefit challenge implementing KFRE riskbased triage guide nephrology referral Universiti Malaya Medical Centre UMMC Kuala Lumpur Malaysia Interviews audio recorded transcribed verbatim thematically analyzed Quantitatively provider job satisfaction survey performed Overall 111 HCPs completed surveys majority mostly satisfied physical surroundings coworkers supervision received Mixed response expressed amount work equipment provided Interviews conducted among 27 HCPs three main CKD care provider group primary care medicine nephrology endocrinology facilitators barriers theme identified top three barrier CKD management suboptimal patients insights gap practice confidences shortfall healthcare system contrast good interdisciplinary network accessibility specialist resource key facilitators underscored importance human resource empowerment continuous patient education structured interdisciplinary collaboration HCPs perceived riskbased triage using KFRE potentially useful targeted care identified several modifiable barrier facilitator warranting attention improve health outcome people CKD riskbased triage approach using KFRE appears promising facilitating targeted nephrology referral better care resource allocations",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40813151/",
        "source_type": "Global"
    },
    {
        "pmid": "40813136",
        "title": "Weight loss leading to reduction in clozapine levels and symptomatic worsening.",
        "abstract": "",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40813136/",
        "source_type": "Global"
    }
]